Abstract
Endophytic fungi include a plethora of species from the phyla Ascomycota, Basidiomycota, and Zygomycota and, for this reason, represent an important part of the fungal diversity. In the past decades, endophytic fungi have demonstrated they can produce different bioactive natural products. Considering that the majority of plants were not yet investigated for their endophytic communities, endophytes still represent an untapped source of secondary metabolites that may be useful to develop new and safe compounds for human and animal health. Furthermore, new strategies can be adopted to recover cryptic and rare species which might produce novel structural scaffolds. Cancer, infectious diseases, and parasitic diseases, among other conditions, still demand special attention and research investments due to their high mortality rates, development of drug resistance, or lack of effective and safe treatment options. In this chapter, we focused on compounds isolated from endophytic fungi recovered from medicinal plants that were evaluated for their antibacterial, antifungal, antiviral, trypanocidal and leishmanicidal, antitumor, antioxidant, and acetylcholinesterase inhibitor activities. A total of 364 compounds are described, which have been isolated from the main genus of fungi Aspergillus, Chaetomium, Diaporthe/Phomopsis complex, Fusarium, and Penicillium. The different studies published strongly suggest that endophytes may contribute to their host plant and for the pharmaceutical industry by producing bioactive substances, as the search for better chemotherapeutic agents remains an important challenge and a constant niche to be explored.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Endophytic fungi
- Medicinal plants
- Bioactive compounds
- Infectious/parasitic diseases
- Cancer
- Antioxidant
- Acetylcholinesterase inhibitors
11.1 Introduction
Endophytic fungi are a diverse group of microorganisms that live asymptomatically in different tissues of living plants (Jia et al. 2016). Despite being important components of plant microhabitat (Jia et al. 2016), endophytic fungi are increasingly present in drug discovery programs mainly due to their capability to produce a diversity of secondary metabolites with pharmacological properties. These fungi may help the host plant in defense against attacking microorganisms, predators, and pests and in return receive their nutrition (Strobel and Daisy 2003; Kaul et al. 2012). From the pharmacological applications perspective, endophytic fungi were reported to produce novel antibacterial, antifungal, antiviral, anti-inflammatory, antitumor, antimalarial, and other bioactive compounds (Nisa et al. 2015; Suman et al. 2016).
According to Strobel and Daisy (2003), Strobel et al. (2004), and Yu et al. (2010), several reasonable plant selection strategies should be followed:
-
1.
Plants growing in areas of great biodiversity also have the prospect of housing larger diversity of endophytes.
-
2.
Plants growing in special habitats, especially those in deteriorated ecological environment, and possessing special capabilities for survival should also be selected for study. People may learn that the power of plants living in such environment may result from the presence of endophytes.
-
3.
Plants surrounded by pathogen-infected plants but showing no symptoms are more likely to lodge endophytes possessing antimicrobial natural products than other plants.
-
4.
Plants that have been exploited for human use as traditional medicines in some place should be considered for study.
-
5.
Plants which occupied a certain ancient land mass are also more likely to lodge endophytes with active natural products than other plants.
The World Health Organization (WHO) defines medicinal plants as “any plant which in one or more of its organs contains substances that can be used for therapeutic purposes or which are precursors for chemo pharmaceutical semi synthesis.” They are frequently selected for screening bioactive compounds (Kaul et al. 2012). The research on endophytic fungi increased considerably after the discovery of taxol, one of the most anticancer agents used in the clinic. This diterpenoid can be produced by the endophytic fungi Taxomyces andreanae (Strobel 2003), and, from their host, the medicinal plant Taxus brevifolia (Stierle et al. 1995). Therefore, from this discovery, it was evidenced that the endophytic fungi might produce the same metabolites of their host plant. However, it is important to highlight that endophytic fungi are also producers of bioactive secondary metabolites that are different from those produced by their hosts and can be of interest for medicinal applications.
11.2 Antibacterial Compounds
Radic and Strukelj (2012) comment on WHO’s constant battle against the ever-increasing multidrug resistance of human pathogenic bacteria, highlighting the urgent need for new alternatives to the currently available broad-spectrum antibiotics. According to Boucher et al. (2009), antibiotic resistance has increased in Gram-positive and Gram-negative pathogens, which represent a serious threat to treatment of infectious diseases. Boucher et al. (2009) also highlight the decrease in the development of new antibacterial drugs and reported a decrease of 75% in new antibacterial drugs over the past 25 years that has been approved by the US Food and Drug Administration (FDA).
The secondary metabolites produced by endophytes associated with medicinal plants may have great potential to treat various infectious diseases. These antimicrobial metabolites are low-molecular-weight organic natural substances active at low concentrations against microorganisms (Guo et al. 2000). The first step toward the discovery of new antibacterial compounds produced by endophytic fungi involves the detection of antibiotic activity in fungal culture extracts. However, in some cases, single compounds present in the crude extract do not show significant antibacterial activity by themselves but can act synergistically in the extract. The identification and structure elucidation of the active metabolite is essential for the development of new antibiotics (Radic and Strukelj 2012). The secondary metabolites with antibacterial activity, isolated from endophytes of medicinal plants between 2008 and 2018, are listed in the Table 11.1.
Liu et al. (2008) suggest that Xylaria sp. YX-28, an endophytic fungus isolated from the medicinal plant Ginkgo biloba L., discloses a potent antimicrobial activity and could be a valuable source of new antimicrobial drugs. From Xylaria sp. YX-28 fermentation broth 7-amino-4-methylcoumarin (4) showed strong antibacterial activities in vitro against Staphylococcus aureus, Escherichia coli, Salmonella typhi, Salmonella typhimurium, Salmonella enteritidis, Aeromonas hydrophila, Yersinia sp., Vibrio anguillarum, Shigella sp., and Vibrio parahaemolyticus with values of minimal inhibitory concentrations (MIC) ranging from 36 to 142.6 μM. Wu et al. (2018) also studied the endophytic fungi associated with Ginkgo biloba L. and obtained Penicillium cataractum SYPF 7131, which generated an extract with strong antibacterial activity. From the crude extract of P. cataractum SYPF 7131 was isolated the compounds penicimenolidyu A (67), penicimenolidyu B (68), and rasfonin (69) that showed antibacterial activity, mainly, toward S. aureus.
A broad diversity of endophytic fungi occurs in the rhizome of Paris polyphylla var. yunnanensis, a medicinal plant used in traditional Chinese medicine. Some studies have explored the biotechnological potential of these fungi in search of new antimicrobials. Among them, Zhao et al. (2010a) report for the first time the antimicrobial metabolites from the endophytic fungus Pichia guilliermondii Ppf9, recovered from rhizome of this plant. From the crude extract of P. guilliermondii Ppf9 were obtained three steroids and one nordammarane triterpenoid, ergosta-5,7,22-trienol (14), 5α,8α-epidioxyergosta-6,22-dien-3β-ol (15), and ergosta-7,22-dien-3β,5α,6β-triol (16) and helvolic acid (17), which showed activity against Agrobacterium tumefaciens, Escherichia coli, Pseudomonas lachrymans, Ralstonia solanacearum, Xanthomonas vesicatoria, Bacillus subtilis, Staphylococcus aureus, and Staphylococcus haemolyticus. The helvolic acid (17) should be the main antimicrobial component in endophytic fungus P. guilliermondii Ppf9 and exhibited the strongest antibacterial activity against A. tumefaciens, E. coli, P. lachrymans, R. solanacearum, X. vesicatoria, B. subtilis, S. aureus, and S. haemolyticus with MIC values of 2.7, 5.5, 5.5, 2.7, 2.7, 5.5, 87.9, and 10.9 μM, respectively. In addition, from the rhizome of the same plant was obtained the endophytic fungus Gliomastix murorum Ppf8, which produced ergosta-5,7,22-trien-3-ol (33) and 2,3-dihydro-5-hydroxy-α,α-dimethyl-2-benzofuranmethanol (34), compounds that were isolated and shown to be active against A. tumefaciens, E. coli, Pseudomonas lachrymans, R. solanacearum, X. vesicatoria, B. subtilis, and S. haemolyticus with the MIC values ranging from 252 to 504 μM. The IC50 values of 34 ranged from 140.3 to 366.4 μM (Zhao et al. 2012a). Two sterols and one fatty acid were obtained from the light petroleum extract of the fungus Fusarium sp. Ppf4, obtained from the rhizomes of P. polyphylla var. yunnanensis: 5α, 8α-epidioxyergosta-6, 22-dien-3β-ol (5) and ergosta-8(9), 22-diene-3β, 5α, 6β, 7α-tetraol (6) and butanedioic acid (7). They were assayed against B. subtilis, S. haemolyticus, A. tumefaciens, E. coli, P. lachrymans, and X. vesicatoria, disclosing MIC values in the range 349.6 μM to 4.47 mM and IC50 values from 202 μM to 1.5 mM (Huang et al. 2009).
Li et al. (2015a) analyzed secondary metabolites from the endophytic fungus Diaporthe sp. LG23 recovered from leaves of Mahonia fortunei (Berberidaceae), a medicinal plant used in China as a potent antimicrobial medicine for treating pneumoconiosis, psoriasis, and cough. From Diaporthe sp. LG23, a new lanosterol derivative, 19-norlanosta-5(10),6,8,24-tetraene-1α,3β,12β,22S-tetraol (43) and six biosynthetically related known ergosterol derivatives were identified. Compound 19-norlanosta-5(10),6,8,24-tetraene-1α,3β,12β,22S-tetraol (43), an unusual fungus-derived 19-nor-lanostane tetracyclic triterpenoid, exhibited pronounced antibacterial efficacy against both Gram-positive and Gram-negative bacteria, especially against clinical isolates of Streptococcus pyogenes, Pseudomonas aeruginosa, and S. aureus, exhibiting MIC values between 0.2 and 10.9 μM.
Wang et al. (2016a) evaluated the antibacterial potential of Colletotrichum sp. BS4 using the OSMAC (One Strain Many Compounds) approach. This fungus was recovered from leaves of the medicinal plant Buxus sinica, and after fractionation of its extracts, three new compounds were isolated and identified: colletotrichones A − C (45–47). Compound colletotrichone A (45) showed pronounced activity against E. coli and B. subtilis, with MIC values of 0.3 and 2.9 μM, respectively, values comparable to that of standard antibiotics. Additionally, colletotrichone C (47) was quite active against the environmental strain of E. coli, with MIC value of 15.7 μM. Furthermore, colletotrichone B (46) was as active as streptomycin against the clinically relevant RG2 bacterium S. aureus, with MIC value of 15.8 μM. Moreover, the authors suggest that Colletotrichum sp. BS4 provides some form of azaphilone-mediated chemical defense to the host plant against invading specialist and generalist bacteria.
Perveen et al. (2017) characterized the secondary metabolites of the endophytic fungus Epicoccum nigrum , recovered from leaves of medicinal plant Ferula sumbul . Compound di-(2-ethylhexyl) phthalate (69) was purified, and its antibacterial potential was evaluated against B. subtilis, S. aureus, and E. coli, showing promising activity with MIC values 8, 3.8, and 14.9 μM, respectively.
11.3 Antifungal Compounds
According to Vallabhaneni et al. (2015), fungal diseases are a considerable cause of morbidity and mortality globally. The treatment of mycoses has several limitations, such as undesirable side effects, narrow activity spectrum, and a small number of targets and fungal resistance, all of which corroborates the urgent need to develop new therapeutic strategies (Fuentefria et al. 2018). As for medicine, the agriculture needs novel antifungal compounds against phytopathogenic fungi, which are responsible for great losses in the world agricultural production. The secondary metabolites produced by endophytes associated with medicinal plants may be used for the fungal treatment. The most important antifungal secondary metabolites from endophytic fungi recovered from medicinal plants, characterized between 2012 and 2018, are listed in Table 11.2 (compounds 1–116).
Carvalho et al. (2018) reported the antifungal activity of the compounds cytochalasin H (117) and J (118) isolated from crude extracts of the endophytic fungi Diaporthe miriciae, UFMGCB 7719 and UFMGCB 6350, recovered from Copaifera pubiflora and Melocactus ernestii, respectively, in Brazil. The compounds were tested against the fungal plant pathogens Colletotrichum fragariae, C. gloeosporioides, C. acutatum, Botrytis cinerea, Fusarium oxysporum, Phomopsis obscurans, and P. viticola using microdilution broth assays. Cytochalasins H and J showed minor mycelial growth stimulation (hormesis) of B. cinerea, C. acutatum, C. fragariae, C. gloeosporioides, and F. oxysporum. The cytochalasins at a concentration of at 300 μmol L−1 caused, after 144 h, 73% and 36% growth inhibition of P. obscurans, respectively, and inhibited the growth of P. viticola by 61% and 58%, respectively. Chapla et al. (2014b) also isolated cytochalasin H (119) from the endophytic fungi Phomopsis sp. obtained from leaves of Senna spectabilis. The compound demonstrated antifungal activity against Cladosporium cladosporioides and C. sphaerospermum inhibiting the fungal growth at 10 and 25 μg/spot, respectively.
Zhang et al. (2014b) reported another cytochalasin from the ethyl acetate extract of the endophyte Xylaria sp. XC-16, recovered from leaves of Toona sinensis. The bioassay-guided fractionation resulted in the isolation of new cytochalasins Z27 (55) and Z28 (56), along with three known compounds seco-cytochalasin E (57), cytochalasin Z18 (58), and cytochalasin E (59). The anti-phytopathogenic activity of the cytochalsins was evaluated on Fusarium solani, Gibberella saubinetti, B. cinerea, and Alternaria solani. Compound 56 showed fungicidal effect against G. saubinetti with MIC of 12.5 μM, a value comparable with that of the positive control hymexazol (MIC of 25 μM). In contrast, other compounds displayed MIC values greater than 50 μM against the tested pathogens (Zhang et al. 2014b).
Phomopsis sp. YM 355364, a fungi obtained from Aconitum carmichaeli growing in China (Wu et al. 2013a), produces the new steroids (14β,22E)-9,14-dihydroxyergosta-4,7,22-triene-3,6-dione (106) and (5α,6β,15β,22E)-6-ethoxy −5,15-dihydroxyergosta-7,22-dien-3-one (107), along with those of calvasterols A and B (108–109) and ganodermaside D (110). Compound 106 exhibited antifungal activities against Candida albicans, Hormodendrum compactum, and Aspergillus niger, with MIC values of 145.3, 145.3, and 290.5 μM. Compound 107 showed weak inhibitory activity against C. albicans and Fusarium avenaceum with MIC of 270.8 μM. Compounds 108 and 110 showed moderate inhibitory activities against F. avenaceum at 151.4 and 156.6 μM, respectively. Compound 108 exhibited weak antifungal activities against Pyricularia oryzae and Trichophyton gypseum with MIC values of 302.9 and 605.8 μM, respectively (Wu et al. 2013a).
Xiao et al. (2013) isolated 80 endophytic fungi from healthy leaves and small branches of Ginkgo biloba (China). All the fungi were tested in an antifungal bioassay against Fusarium graminearum, Sclerotinia sclerotiorum, and Phytophthora capsici by the agar diffusion method. Fifteen endophytes were active against at least one of the tested fungi, and Chaetomium globosum CDW7 yielded the most bioactive culture which, after threefold dilution, completely inhibited in vitro the mycelial growth and conidia germination of F. graminearum. The in vivo protective efficacy of the diluted broth was 54.9% and its curative efficacy 48.8%. Bioassay-guided fractionation resulted in the isolation of 1,2-benzenedicarboxaldehyde-3,4,5-trihydroxy-6-methyl (flavipin) (102) that inhibited the growth of the plant-pathogenic fungi F. graminearum (EC50 value of 3.7 μM), S. sclerotiorum (EC50 value of 18.8 μM), Rhizoctonia solani (EC50 value of 13.4 μM), P. capsici (EC50 value of 14.1 μM), and Alternaria solani (EC50 value of 63 μM) (Xiao et al. 2013). In a more recent work, Zhao et al. (2017) reinvestigated Chaetomium globosum CDW7 and reported the isolation of six known compounds, namely, chaetoglobosins A–E and Vb. Chaetoglobosins A (7) and D (8) exhibited inhibitory activity against S. sclerotiorum with IC50 values of 0.6 and 1.2 μM, respectively (Zhao et al. 2017).
Zhang et al. (2013) studied the endophytic fungi Chaetomium globosum , associated with G. biloba growing in China, and isolated the alkaloids chaetoglobosins A, C, D, E, G, and R (120–125) along with ergosterol (126), allantoin (127), and uracil (128). Chaetoglobosins A, C, D, E, G, and R (120–125) showed significant growth inhibitory activity against the phytopathogenic fungi Rhizopus stolonifer and Coniothyrium diplodiella at a concentration of 20 μg/disc. Cao et al. (2016) reported that Nodulisporium sp. A2, associated with leaves of G. biloba, as producer of the sporothriolide (129), a metabolite produced by the fungus, showed potent antifungal activity against Rhizoctonia solani and Sclerotinia sclerotiorum and inhibits conidium germination of Magnaporthe oryzae in vitro and in vivo.
Xu et al. (2016) described a new monoterpene lactone (3R,4R,6R,7S)-7-hydroxyl-3,7-dimethyl-oxabicyclo[3.3.1]nonan-2-one (25) and the known compound (3R, 4R)-3-(7-methylcyclohexenyl)-propanoic acid (26) from Pestalotiopsis foedan, an endophyte fungus obtained from the branch of Bruguiera sexangula occurring in China. Both compounds exhibited strong antifungal activities against B. cinerea and Phytophthora nicotianae with MIC values of 3.1 and 6.3 μg mL−1, respectively, values close to the MIC of the antifungal drug control ketoconazole (3.1 μg mL−1). Compound 26 also displayed modest antifungal activity against C. albicans, with a MIC value of 50 μg mL−1 (Xu et al. 2016).
Bioassay-guided fractionation of the endophytic fungus Phoma sp., isolated from roots of Eleusine coracana, resulted in the identification of four antifungal compounds, 3-hydroxy-4-(3-hydroxyphenyl)-2-quinolonemonohydrate (viridicatol alkaloid) (130), 3-acetyl-5-sec-butyltetramicacid (tenuazonic acid) (131), alternariol (132), and alternariol-5-O-methyl ether or djalonensone(3,7-dihydroxy-9-methoxy-1-methyl-6H-dibenzo[b,d]pyran-6-one) (133). The antifungal activity of the compounds 130–133 was evaluated using the agar disc diffusion method (20 μl of 5 mg mL−1) and produced growth inhibition zones of 1.8, 2, 1.5, and 1.5 mm, respectively (Mousa et al. 2015). The extract of the endophytic Seimatosporium sp., isolated from Salsola oppositifolia (Spain), was further purified to give pure new compound, 5,6,7,8-tetrahydro-1,5-dihydroxy-3-methoxy-8-oxonaphthalene-2-carbaldehyde (seimatorone) (134), and the known compounds, 1-(2,6-dihydroxyphenyl)-3-hydroxybutan-1-one (135), 1-(2,6-dihydroxyphenyl)butan-1-one (136), 1-(2-hydroxy-6-methoxyphenyl)butan-1-one (137), 5-hydroxy-2-methyl-4H-chromen-4-one (138), 2,3-dihydro-5-hydroxy-2-methyl-4H-chromen-4-one (139), 8-methoxynaphthalen-1-ol (140), nodulisporin A (141), nodulisporin B (142), and daldinol (143). Seimatorone demonstrated antifungal activity against Microbotryum violaceum in the agar diffusion assay with partial inhibition, once there was some growth within the zone of inhibition (Hussain et al. 2015).
Chapla et al. (2014a) characterized the new compound, 2-phenylethyl 1H-indol-3-yl-acetate (144), and seven known compounds, uracil (145), cyclo-(S*-Pro-S*-Tyr) (146), cyclo-(S*-Pro-S*-Val) (147), 2(2-aminophenyl)-acetic acid (148), 2(4-hydroxyphenyl)acetic acid (149), 4-hydroxybenzamide (150), and 2-(2-hydroxyphenyl)-acetic acid (151), from the endophytic fungus Colletotrichum gloeosporioides associated with leaves of Michelia champaca (Magnoliaceae) growing in São Paulo, Brazil. All compounds were evaluated for their antifungal activities against two phytopathogenic fungi, C. cladosporioides and C. sphaerospermum , using the Thin-layer chromatography (TLC) diffusion method at 100 μg/spot and nystatin at 1 μg/spot as positive control. Compounds 144, 150, and 151 exhibited activity against both fungal species, while compound 149 was highly active against C. cladosporioides but showed only moderate activity on C. sphaerospermum. When compounds 144, 149, 150, and 151 were evaluated at doses ranging from 1 to 100 μg/spot, 144 exhibited potent antifungal activity at 5 μg, which was similar to that observed for the positive control (nystatin), demonstrating the potential of 144 as an antifungal agent. Compounds 149, 150, and 151 exhibited moderate antifungal activity at 25 μg (Chapla et al. 2014a).
The ethyl acetate extract of endophytic fungus Coniothyrium sp., isolated from Salsola oppositifolia (Canary Islands), afforded the known hydroxyanthraquinones, pachybasin (152), 1,7-dihydroxy-3-methyl-9,10-anthraquinone (153), phomarin (154), and 1-hydroxy-3-hydroxymethyl-9,10-anthraquinone (155), together with four new derivatives having a tetralone moiety, namely, coniothyrinones A–D (156–159). When tested in the agar diffusion assay (0.05 mg) on Microbotryum violaceum, B. cinerea, and Septoria tritici, compounds 154, 155, and 156 showed strong antifungal activity against M. violaceum (10, 8, and 7.5 mm of the zone of inhibition, respectively) and B. cinerea (9, 9, and 12.5 mm of the zone of inhibition, respectively) (Sun et al. 2013).
Huang et al. (2015) obtained five new guaiane sesquiterpenes 49–53 from the culture broth of the endophytic fungus Xylaria sp. YM 311647, which were isolated from Azadirachta indica . The compounds were evaluated against the pathogenic fungi C. albicans, A. niger, P. oryzae, F. avenaceum, and Hormodendrum compactum by means of the broth microdilution method. All compounds exhibited moderate or weak antifungal activities against P. oryzae and H. compactum with MIC values varying from 111 to 939.9 μM, with compound 52 being the most active against P. oryzae. Compounds 51 and 52 exhibited moderate antifungal activities against H. compactum with MIC value 221.9 μM. In addition, compounds 52 and 53 showed the most potent antifungal activities against C. albicans with MIC values of 110.96 and 111.7 μM, respectively. Compound 51 showed moderate inhibitory activities against C. albicans, A. niger, and H. compactum with MIC value of 221.9 μM. None of the compounds showed activity against F. avenaceum (Huang et al. 2015).
Two new tetranorlabdane diterpenoids, named botryosphaerin G (160) and H (161), along with seven known tetranorlabdane diterpenes, 13,14,15,16-tetranorlabd-7-en-19,6β:12,17-diolide (162), botryosphaerin A (163), 3a,10b-dimethyl-1,2,3,3a,5a,7,10b,10c-octahydro-5,8-dioxa-acephenanthrylene-4,9-dione (164), acrostalidic acid (165), botryosphaerin B (166), LL-Z1271β (167), and acrostalic acid (168), were isolated from the endophytic fungus Botryosphaeria sp. P483 associated with the Chinese medicinal plant Huperzia serrata. Compounds 161 and 162 showed antifungal activity against phytopathogenic fungi Gaeumannomyces graminis, Fusarium moniliforme, F. solani, F. oxysporum, and Pyricularia oryzae using the disk diffusion method at 100 μg/disk (Chen et al. 2015).
Pereira et al. (2015) demonstrated that the crude extract of the endophytic fungus Mycosphaerella sp. UFMGCB 2032, recovered from Eugenia bimarginata (Brazil), exhibited outstanding antifungal activity against Cryptococcus neoformans and C. gattii, with MIC values of 31.2 μg mL−1 and 7.8 μg mL−1, respectively. The fractionation of this extract afforded two eicosanoic acids, (2S,3R,4R)-(E)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxoeicos-6,12-dienoic acid (47) with MIC values of 3.3 and 6.3 μM against C. neoformans and C. gattii, respectively, and myriocin (48), with MIC values of 1.24 μM to both targets. Nalli et al. (2015) reported the identification of four new bioactive metabolites, phialomustin A–D (169–172), isolated from the endophytic fungus Phialophora mustea associated with the corms of Crocus sativus. Compounds 171 and 172 showed antifungal activities against C. albicans with IC50 values of 14.3 and 73.6 μM, respectively. Compound 171 was active against A. fumigatus, A. parasiticus, and A. flavus with IC50 values of 60.6, 35.2, and 84.4 μM, respectively (Nalli et al. 2015).
The chemical evaluation of the crude extract of the endophytic Guignardia sp., from Euphorbia sieboldiana leaves, led to the isolation of nine new meroterpenes, guignardones J-L (173–175), 13-hydroxylated guignardone A (176), 12-hydroxylated guignardone A (177), 17-hydroxylated guignardone A (178), guignardones M-O (179–181), and a new dioxolanone derivative, 10-hydroxylated guignardianone C (182), together with seven known compounds, guignardones A-C (183–185), guignardones G and H (186–187), guignardic acid (188), and palmarumycin C11 (189). The compounds were evaluated for their inhibitory effects alone and with fluconazole on the growth and biofilms of C. albicans. At 6.3 μg mL−1 concentration, combined with 0.031 μg mL−1 of fluconazole, compounds 180 and 188 showed inhibition on the growth of C. albicans with fractional inhibitory concentration index values of 0.2 and 0.2, respectively (Li et al. 2015b).
Altenusin (190), isoochracinic acid (191), altenuic acid (192), and 2,5-dimethyl-7-hydroxychromone (193) were isolated from Alternaria alternata associated with Terminalia chebula (Thailand). All compounds were investigated for their activity on Candida albicans using disc diffusion assay. Altenusin (190) exhibited weak activity against C. albicans with an unclear inhibition zone diameter of 8.3 mm (at the concentration of 256 μg/disc). In the presence of a subinhibitory concentration of ketoconazole at 0.1 μg mL−1, altenusin produced a clear inhibition zone diameter of 19.2 mm (Phaopongthai et al. 2013).
Li et al. (2014) obtained six new isocoumarin derivatives, exserolides A–F (194–199), together with four known metabolites, monocerin (200), 11-hydroxymonocerin (201), (12R)–(202), and (12S)-12-hydroxymonocerin (203). They were isolated from the ethyl acetate (EtOAc) extract of endophytic fungus Exserohilum sp., recovered from the leaves of Acer truncatum (China). All the compounds were tested for their antifungal activity against the plant pathogenic fungus F. oxysporum. Compounds 196 and 202 displayed MIC value of 20 μg mL−1, while the positive control amphotericin B showed a MIC value of 0.6 μg mL−1 (Li et al. 2014). Two compounds named cis-4-acetoxyoxymellein (204) and 8-deoxy-6-hydroxy-cis-4-acetoxyoxymellein (205) were identified by Hussain et al. (2014) from an unidentified endophytic fungus isolated from Meliotus dentatus. Both compounds showed significant antifungal effect toward M. violaceum, B. cinerea, and Septoria tritici when tested in the agar diffusion assay.
Carvalho et al. (2016) reported the identification of the compounds (−)-5-methylmellein (206) and (−)-(3R)-8-hydroxy-6-methoxy-3,5-dimethyl-3,4-dihydroisocoumarin (207) from the endophytic Biscogniauxia mediterranea EPU38CA associated with Echinacea purpurea (USA). The compounds were evaluated against plant pathogenic fungi at a dose of 300 μM, with the compound 206 showing weak activity against P. obscurans, P. viticola, and F. oxysporum with 43.5, 36, and 5% of inhibition, respectively. Using the same methodology, compound 207 showed antifungal activity against B. cinerea (58%), P. viticola (50%), and P. obscurans (70%). B. mediterranea was also isolated from the plant Opuntia humifusa (USA) by Silva-Hughes et al. (2015) and yielded (−)-5-methylmellein (208), a compound that displayed moderate antifungal activity against the phytopathogenic fungi P. obscurans (63.5% growth inhibition) and F. oxysporum (20.1%).
Kajula et al. (2016) identified three new epithiodiketopiperazine natural products, outovirin A–C (209–211), produced by the endophytic fungus Penicillium raciborskii isolated from Rhododendron tomentosum . The authors evaluated the antifungal activity of the compounds against F. oxysporum, B. cinerea, and Verticillium dahliae by microspectrophotometry using a dose-response growth inhibition assay. Outovirin C inhibited growth of all fungal isolates at a low concentration of 0.4 mM, but a more significant growth inhibition was observed at the higher concentration of 0.8 mM. This compound was most active against B. cinerea (57% inhibition) and slightly less effective against V. dahliae (45% inhibition) (Kajula et al. 2016).
Four new compounds, murranofuran A (212), murranolide A (213), murranopyrone (214), and murranoic acid A (215), along with six known metabolites, N-(2-hydroxy-6-methoxyphenyl)acetamide (216), curvularin (217), (S)-dehydrocurvularin (218), pyrenolide A (219), modiolide A (220), and 8-hydroxy-6-methoxy-3-methylisocoumarin (221), were identified from the Curvularia sp., an endophytic fungus isolated from Murraya koenigii (Bangladesh). The compounds were subjected to motility, inhibitory, and zoosporicidal activity tests against Phytophthora capsici at different concentration and time-course activities. The most noticeable zoospore motility-inhibitory activity was exhibited by pyrenolide A (219), where the highest activity (100%) was achieved at a very low concentration (0.5 μg mL−1) within a short time (30 min). Compounds 213, 214, 217, 218, 220, and 221 exhibited zoospore motility impairment activity, but with IC50 values in the range 50–100 μg mL−1 (Mondol et al. 2017).
Silva et al. (2017a) described the isolation, structure, and antifungal activity of three new isoaigialones, A–C (222–224), along with aigialone (225) from the endophytic fungus Phaeoacremonium sp. isolated from leaves of Senna spectabilis (Brazil). Using direct bioautography all the compounds were evaluated against C. cladosporioides and C. sphaerospermum. The compounds 223 and 225 exhibited antifungal activity, with a detection limit of 5 μg/spot, for both species of Cladosporium, while compound 224 displayed weak activity (detection limit >5 μg/spot), with a detection limit of 25 μg/spot.
The compounds epicolactone (226) and epicoccolides A and B (227–228), together with seven known metabolites, were obtained from the endophytic fungus Epicoccum sp. CAFTBO isolated from Theobroma cacao . The compounds 226–228 exhibited antifungal activity in the agar diffusion test against Pythium ultimum and Rhizoctonia solani with MIC values of 20–80 μg/disk (Talontsi et al. 2013).
11.4 Antiviral Compounds
Viral diseases are among the greatest concerns among the infectious diseases. WHO has released a list of priority diseases and pathogens for the year 2018 and among these diseases are Crimean-Congo hemorrhagic fever, Ebola, Zika, and Chikungunya virus (OPAS - OMS 2018). Thus, recent research attempts to identify antiviral compounds to produce vaccines, aiming at an immunization of the population.
As already mentioned, endophytic fungi are a promising source of biologically active secondary metabolites with numerous applications, including the production of antiviral compounds (Pamphile et al. 2017). However, there had been few reports on antiviral metabolites from endophytic fungi, even though those found show promising results (Kaul et al. 2012). Zhang et al. (2011a, b) isolated from the inner shell of Aegiceras corniculatum the endophytic fungus Emericella sp. that can produce two isoindolone derivatives. These two substances showed moderate antiviral activity with IC50 of 42.1 and 62.1 μg mL−1, against influenza A (H1N1). Aegiceras corniculatum is a plant that grows in mangroves of tropical and subtropical regions. Species of Aegiceras are known to be used in the treatment of ulcers, liver damage, asthma, diabetes, and rheumatism and as an anti-inflammatory agent (Roome et al. 2008).
Guo et al. (2000) isolated the endophytic Cytonaema sp. from tissues of Quercus sp., which was able to produce the cytonic acids A and B and described as having antiviral activity since they are inhibitors of human cytomegalovirus protease, with IC50 of 43 μM and 11 μM, respectively. Plants of this genus are used by indigenous peoples in Canada for the treatment of diabetes and its complications (McCune and Johns 2002).
Hinnuloquinone is another antiviral compound that inhibits human immunodeficiency virus type 1 protease (HIV-1) (Singh et al. 2004; Kumar et al. 2014). This compound had already been isolated from an endophytic fungus associated with the leaves of Quercus coccifera (Baker and Satish 2015). Quercus coccifera is used for wound healing in the villages of Yunt Mountain in Turkey (Ugurlu and Secmen 2008).
Pullarin A is a compound produced by the endophytic Pullaria sp., which was reported to be associated with the leaves of Caulophyllum sp. grown in Thailand. This compound showed antiviral activity with IC50 of 3.3 μg mL−1 against herpes virus type 1 - HSV-1 (Isaka et al. 2007; Borges et al. 2009).
11.5 Antitumor Compounds
According to the WHO, the number of deaths caused by the diverse types of cancer in the world can reach 8.8 million people annually. Estimates indicate that 14 million people develop cancer every year and by 2030 that number should reach 21 million people (OPAS/OMS 2017). As a result, the search for new treatments has grown significantly throughout the world. The search of anticancer secondary metabolites produced by endophytic fungi associated with medicinal plants has been studied since the discovery of taxol, first isolated from the bark of Taxus brevifolia in 1971. Taxol has proven efficacy against prostate, ovarian, breast, and lung cancers (Zhao et al. 2010b; Manju et al. 2012). Interestingly, taxol was also found in Taxomyces andreanae, an endophytic fungus isolated from the bark of T. brevifolia. Other studies demonstrated that taxol can be produced by endophytic fungi isolated from other plants (Pandi et al. 2011). Qiao et al. (2017), for example, isolated the taxol from the endophytic fungus Aspergillus aculeatinus, isolated from the inner and outer bark of the plant Taxus chinensis var. mairei. The endophytic fungus Cladosporium sp., isolated from the leaves and stem of the Taxus baccata plant in the northern forest of Iran, was also able to produce taxol (Kasaei et al. 2017). Taxol prevents tubulin molecules from depolymerizing during cell division processes. This happens because this compound inhibits cell replication and migration, stopping the cycle of division of mitosis in late phase G2 (Strobel and Daisy 2003; Yang and Horwitz 2017).
Camptotheca acuminata is a plant native to central China and widely used in the popular medicine. This species is rich in camptothecin (Lin et al. 2007), an anticancer compound that acts on the enzyme topoisomerase I which is responsible for the relaxation or not of the DNA molecule during the processes of replication and transcription (Kusari et al. 2009). It was later found that the endophytic fungus Fusarium solani, originating from the inner bark of this C. acuminata was also able to produce camptothecin (Kusari et al. 2012). Moreover, there are also reports of its production by other endophytic fungi associated with other plant species, for example, the endophytic fungus Entrophospora infrequens isolated from the inner bark of Nothapodytes foetida syn. N. nimmoniana (Gowda et al. 2002; Puri et al. 2005). This plant, growing on the west coast of India, is used as anticancer, antimalarial, bactericidal, antioxidant, anti-inflammatory, and fungicidal, to treat anemia and HIV infections (Khan et al. 2013). Su et al. (2014) isolated camptothecin from the endophytic fungi Alternaria alternata, C. gloeosporioides, Fusarium nematophilum, and Phomopsis vaccinia, all isolated from the leaves, twigs, and roots of C. cuminata. From this plant yet another endophytic fungus, Fusarium solani, also produces camptothecin (Ran et al. 2017).
Podophyllum hexandrum is a plant that lives in high altitudes and is native to alpine and subalpine areas of the Himalayas. It has been used since antiquity in traditional Indian and Chinese medicine to treat metabolic imbalance. More recently, its activity against monocytic leukemia, Hodgkin’s and non-Hodgkin’s lymphomas, bacterial and viral infections, venereal warts, rheumatoid arthralgia associated with limb numbness, and different types of cancer, such as brain, lung, and bladder, has been described (Chawla et al. 2005). Podophyllum hexandrum produces a substance called podophyllotoxin that is a precursor to the synthesis of three anticancer compounds: etoposide, teniposide, and etoposide phosphate (You 2005). These compounds inhibit DNA topoisomerase II and are used to treat cancer of the lung, testicles, and some leukemias, among others (Xu et al. 2009; Chandra 2012). Puri et al. (2006) isolated the endophytic fungus Trametes hirsuta from the rhizomes of P. hexandrum, which was able to produce podophyllotoxin under laboratory conditions. It has also been isolated from the endophytic Fusarium oxysporum associated with the plant Juniperus recurva (Kour et al. 2008). Phialocephala fortini, an endophytic fungus associated with Podophyllum peltatum, also produces this substance. In India, this plant is used in the treatment of snakebite, cancer, vermifuge, and ulcers (Eyberger et al. 2006; Silva et al. 2017b). Podophyllotoxin was also isolated from the endophytic Fusarium solani isolated from the root of the plant P. hexandrum (Nadeem 2012).
Ergoflavine is an anticancer compound isolated from the Indian medicinal plant Mimusops elengi (Kaul et al. 2012). All parts of this plant are known to have medicinal properties. The fruits are used for chronic dysentery and constipation; the flowers relieve headaches and are used against ulcer; and the bark is used to increase fertility in women and also has activity against ulcer (Verekar et al. 2017). Deshmukh et al. (2009) isolated from the leaves of M. elengi an endophytic fungus that was shown to produce ergoflavine, significantly active against the proliferation of pancreatic, renal, and lung cancer cells.
Cytochalasins are a large group of secondary metabolites produced by various species of fungi, comprising about 60 different compounds. The first cytochalasins to be studied were A and B. They inhibit actin, sugar uptake, and blocks ion channels (Goietsenoven et al. 2011). Pongcharoen et al. (2006) isolated cytokinins produced by the endophytic fungus Eutypella scoparia associated with the plant Garcinia dulcis. In Thailand, G. dulcis leaves are used for the treatment of inflammation in the lymphatic, mumps, and goiter ducts (Abu et al. 2015). Wagenaar et al. (2000) also report the production of cytochalasins by another endophytic fungi, Rhinocladiella sp., isolated from Tripterygium wilfordii. This plant is endemic in southern China and used to treat immune and inflammatory diseases (OuYang et al. 2007). Caetoglobesins are cytochlasin arrays, and many of them are toxic to human cancer cell lines. More than 40 have been identified and many of them are produced by fungi (Zhang et al. 2010). Caetoglobosin U, a secondary metabolite of the endophytic fungus Chaetomium globosum, isolated from the medicinal plant Imperata cylindrica, used in the treatment of dysentery and urinary tract infections, was shown to display anticancer activity (Ding et al. 2006; Krishnaiah et al. 2009). Caetoglobesins C, E, and F, among others, were also isolated from this fungal species, but this time isolated from the G. biloba plant (Li et al. 2014). The seeds of this plant are used for the treatment of asthma and cough and the leaves are used for heart problems and skin infections (Mahadevan and Park 2008).
Vincristine is another anticancer compound and acts by disrupting mitosis by binding to tubulin dimers, inhibiting the assembly of microtubules (Aly et al. 2010). Kumar et al. (2013) isolated vinscritin from the culture of endophytic fungus Fusarium oxysporum, which was associated with the medicinal plant Catharanthus roseus. The roots of this plant are used to control blood pressure, and this characteristic is related to the alkaloids present in it. Table 11.3 shows other anticancer compounds isolated from endophytic fungi of medicinal plants in the last 8 years.
11.6 Acetylcholinesterase Inhibitors
Alzheimer’s disease (AD) is an age-related neurodegenerative disease with cognitive and neuropsychiatric manifestations that result in progressive disability (Zhao and Tang 2002). According to Alzheimer’s Disease International (ADI), 47 million people lived with dementia in the world in 2016 and this number can increase to more than 131 million by 2050 as populations age. That can be related to the AD that lead to a progressive decline in cognitive function that is substantially increased among people aged 65 years or more (Prince et al. 2016).
Cholinesterase inhibitors are important substances recommended for the treatment of cognitive deficits and associated behavioral abnormalities in patients with mild-to-moderate AD (Weinstock 1999; Ballard 2002). The cholinesterase inhibitors can inactivate the enzyme acetylcholinesterase (AChE), preventing the inactivation of acetylcholine (Ach) after its release from the neuron, increasing its ability to stimulate nicotinic and muscarinic receptors (Weinstock 1999; Zhao and Tang 2002). There are no available treatments that stop or reverse the progression of the disease, fact that reinforces the importance of developing medicines that would at least slow the progression of the symptoms (Duthey 2013).
Oliveira et al. (2011) reported the AChE inhibition of (3R,4R)-3,4-dihydro-4,6-dihydroxy-3-methyl-1-oxo-1H-isochromene-5-carboxylic acid produced by the fungus Xylaria sp., isolated from the plant Piper aduncun with minimum amount required for inhibition of 3 μg compared with the galantamine used as positive control with minimum amount required for inhibition of 1 μg. Singh et al. (2012) screened endophytic fungi associated with Ricinus communis for its inhibitory activity on AChE. They found six active strains, and the best results were from the extract of the fungus Alternaria sp. with 78% of inhibition and an IC50 of 40 μg mL−1. Na et al. (2016) isolated the fungus Geomyces sp. from the plant Nerium indicum that showed high inhibitory activity with an IC50 value of 5.2 μg mL−1 that might be related to substances derived from vincamine produced by this fungus. Chapla et al. (2014a) identified six fungal isolates with inhibitory AChE activity recovered from the medicinal plant Michelia champaca, with the species C. gloeosporioides, Phomopsis stipata, and Xylaria sp. showing the highest activity.
Wang et al. (2016b) investigated the medicinal plant Huperzia serrata from the Jinggang Mountain region (China) for the presence of endophytic fungi with acetylcholinesterase inhibitory activity. From the 247 strains isolated, 221 generated extracts with in vitro AChE inhibitory activity, with 4 of them, namely, Coletotrichum spp., Ascomycota spp., Sarcosomataceae spp., and Dothideomycetes spp. causing more than 80% inhibition. Dong et al. (2014) analyzed H. serrata from the Tianmu Mountains of Hangzhou (China) for endophytic fungi producing huperzine A (HupA), a substance produced by the plant itself and known for its high AChE inhibitory activity. They found that the fungus Trichoderma sp. seems to produce this substance, yielding an extract capable of inhibiting AChE by 81.9%. The fungi recorded for producing HupA and other potential substances are listed in the Table 11.4.
11.7 Antioxidant Activity
Antioxidant substances protect cells from injury caused by free radicals produced by the natural metabolism during aerobic respiration (Yehye et al. 2015). These radicals have an important physiological role but may cause toxic effects leading to degenerative diseases like cancer and Alzheimer’s disease (Kaul et al. 2012; Yehye et al. 2015). The antioxidant activity of endophytic fungi extracts might be related to the production of flavonoid and phenolic compounds, making them act as reducing agents and hydrogen donors due to their redox properties (Qiu et al. 2010; Khan et al. 2017). Besides the uses in the pharmaceutical industry, the potent activity found in the endophytic extracts can be used as a natural antioxidant in the food industry (Nath et al. 2012; Rana et al. 2018a, b; Yadav et al. 2017). The importance of exploring new sources of effective antioxidants is related to the low number of antioxidants approved for clinical applications (Kaul et al. 2012).
The compound 1.1-diphenyl-2-picrylhydrazyl (DPPH) is a stable free radical widely accepted as a tool to analyze the antioxidant ability of extracts. When a substance with antioxidant activity interacts with DPPH, it transfers electrons or hydrogen atoms neutralizing its free radical character and causing changes in its color (Naik et al. 2003). Using this method, Singh et al. (2016) found phenolic compounds with IC50 value of 22.5 μg mL−1 in the extract of the endophytic fungus Cladosporium velox, isolated from the medicinal plant Tinospora cordifolia.
Tejesvi et al. (2008) searched for antioxidant activity in endophytic Pestalotiopsis species associated with medicinal plants growing in southern India. They found three fungi with significant scavenging activity (over 80%): Pestalotiopsis theae (TA-37), isolated from the bark of the medicinal plant Terminalia arjuna, presenting an IC50 value of 14 μg mL−1; Pestalotiopsis sp. 3 (TA-60), isolated from the root of Terminalia arjuna with an IC50 value of 25 μg mL−1; and Pestalotiopsis virgatula, isolated from the bark of Terminalia chebula with an IC50 of 27 μg mL−1.
Nath et al. (2012) found four endophytic fungi with antioxidant activity occurring in the medicinal plant Emblica officinalis. The fungus Phomopsis sp. isolated from the stem showed the most significant IC50 value of 17.4 μg mL−1, a value comparable with that of ascorbic acid (15 μg mL−1) used as positive control. In addition, the fungi identified as Diaporthe sp. and Xylaria sp., isolated from the root and stem of Epacris sp., were also considered active, with IC50 values in the range of 18.9 μg mL−1–29.4 μg mL−1. The same group studied the fungi Cholletotrichum gloeosporoides, Penicillium sp., and Aspergillus awamori, all isolated from the plant Rauwolfia serpentina, for their ability to produce antioxidant compounds showing that A. awamori was most effective with extract disclosing the highest scavenging activity in the DPPH test (Nath et al. 2013).
Khiralla et al. (2015) investigated five Sudanese medicinal plants for endophytic fungi with potential antioxidant activity. Among 21 endophytes isolated, the fungus Aspergillus sp. from the seed of Trigonella foenum-graecium showed the most significant results, with an IC50 value of 18.0 μg mL−1 in the DPPH assay. Jayanthi et al. (2011) reported that a Phomopsis sp. isolated from the medicinal plant Mesua ferrea disclosed an IC50 value of 31.3 μg mL−1, while the positive control, ascorbic acid, showed an IC50 value of 11.1 μg mL−1.
Shukla et al. (2012) showed that Paecilomyces variotti, one of the endophytic fungi isolated from the root of Ocimum sanctum, yielded an extract with IC50 value of 71.8 μg mL−1 in the DPPH test and 110.9 μg mL−1 for the scavenging of the hydroxyl radical. Yadav et al. (2014) disclosed the antioxidant activity and total phenolic content (TPC) of endophytic fungi isolated from Eugenia jambolana. They found two potential fungi with scavenging activity higher than 80%, Chaetomium sp. that present the highest concentration of phenolic compounds among all isolates and Aspergillus sp. Other two techniques were used to measure the antioxidant activity of these fungi: hydrogen peroxide scavenging assay and reducing power assay, confirming the antioxidant potential of compounds produced by these fungi.
Bhagobaty and Joshi (2012) isolated endophytic fungi from plants growing in the “sacred forests” of India. They measured their antioxidant potential using DPPH and FRAP assays. The latter measures the UV absorbance of ferrous ions. The tests showed that the fungus Mortierella hyalina, isolated from the plant Osbeckia stellata, has a good potential, with a FRAP value of 1.316 μM and a percentage of free radical scavenging activity of 79.7%. In these assays, the control substance ascorbic acid has a FRAP value of 2.000 μM and free radical scavenging activity of 64%.
Huang et al. (2007) isolated bioactive fungi from the medicinal plant Nerium oleander and used the ABTS method to test the total antioxidant capacity of the fungi extracts. Most of the fungal strains (75%) showed moderate antioxidant capacities with values ranging from 20 to 50 μmol trolox/100 mL culture. The fungus Chaetomium sp. presented the highest antioxidant capacity, that is, 151 μmol trolox/100 mL culture.
Srinivasan et al. (2010) evaluated the antioxidant property of the endophytic fungus Phyllosticta sp. isolated from the leaves of Guazuma tomentosa using the DPPH and ABTS methods. The results showed the potential antioxidant of the fungus extract, that contains phenolic and flavonoid substances, with EC50 values of 580 μg mL−1 for the DPPH radical test and 2030 μg mL−1 for the ABTS radical test.
Qiu et al. (2010) identified two flavonoid-producing endophytic fungi with antioxidant activity in the twigs of G. biloba. Aspergillus nidulans and Aspergillus oryzae showed antioxidant activity on the hydroxyl radical scavenging activity test of 34% and 58%, respectively. Substances from endophytic fungi isolated from medicinal plants that present antioxidant activity are listed in the Table 11.5.
11.8 Neglected Tropical Diseases
Neglected tropical diseases (NTDs) are a diverse group of infectious diseases caused by bacteria, parasites, protozoans, or viruses, which prevail especially in tropical and subtropical regions (Lenzi et al. 2018). According to reports published by World Health Organization (WHO), the diseases of major concern are Chagas disease and visceral leishmaniasis (WHO 2017).
The frequency of drug-resistant parasites has greatly increased, and most treatments involve highly toxic drugs. In addition, the chemotherapeutic agents used in patients with these diseases have lacked effectiveness. Thus, there is an urgent need to search for novel drugs from previously unexplored sources, including natural products, to combat the global health problems posed by parasitic infections (Martínez-Luis et al. 2011).
Historically, natural products are a good strategy when searching for new bioactive compounds, they provide a basis for both design and synthesis of derivative compounds aiming at optimizing biological activity and minimizing side effects (Scotti et al. 2010; Schulze et al. 2015). The ongoing development of new antiparasitic agents is important to overcome the limitations related to the high toxicity of the drugs currently available for the treatment of diseases caused by tropical parasites (Croft et al. 2006). Despite advances in the discovery and development of plant-derived drugs, NTDs continue to cause morbidity and mortality in hundreds of millions of people, especially in poor areas (Goupil and McKerrow 2014).
While endophytic fungi are an abundant and reliable source of metabolites with medicinal and agrochemical applications, they have been only scarcely explored as sources of antiparasitic agents (Martínez-Luis et al. 2011). Because these fungal endophytes are promising sources of bioactive metabolites, they could be used to produce important antiparasitic compounds to treat NTDs such as trypanosomiasis, leishmaniasis, and malaria.
11.8.1 Trypanosomiasis
Chagas disease (or American trypanosomiasis) is a parasitic illness that results from infection by the hemoflagellate protozoan Trypanosoma cruzi (T. cruzi). The transmission of Chagas disease occurs primarily through the bite of an infected triatomine bug on an individual. Triatomines are insects that usually belong to the genera Triatoma, Rhodnius, or Panstrongylus, which are commonly known as “barbeiros” in Brazil and “kissing bugs” in the United States, due to their preference for biting the faces of sleeping people. These insect genera include more than 140 species, of which 61 are endemic to Brazil (Costa and Peterson 2012). According to WHO, and in common with other neglected tropical diseases, “Chagas disease is a proxy for poverty and disadvantage: it affects populations with low visibility and little political voice, causes stigma and discrimination, is relatively neglected by researchers, and has a considerable impact on morbidity and mortality” (Coura and Dias 2009).
Approximately 7–eight million individuals have Chagas disease, and 50,000 new cases are diagnosed every year in Latin America, North America, and Europe. It is estimated that more than 90 million individuals are currently at risk of infection with the Chagas disease’s etiologic agent (Coura and Dias 2009; WHO 2014; Vazquez et al. 2015). The conventional treatment is based on benzimidazole (Bayer Health Care—Lampit®) and nifurtimox (Roche— Rochagan® or Radanil®), which were developed over 100 years ago. Both drugs have strong side effects, such as appetite loss, vomiting, polyneuropathy, and dermopathy. The long-term treatment required combined with the strong side effects contributes to frequent desistence (Guedes et al. 2011). Additionally, benzimidazole and nifurtimox are mostly effective for the blood forms in the acute phase and not so effective against the intracellular forms in the chronic phase (Muelas-Serrano et al. 2002).
Human African trypanosomiasis (or sleeping sickness) is a fatal vector-borne parasitic disease caused by Trypanosoma brucei brucei transmitted by the tsetse fly (Glossina spp.). This neglected tropical disease occurs only in rural areas of sub-Saharan Africa (Simarro et al. 2011). To date, only a few drugs have been approved for the treatment of human African trypanosomiasis. These include suramin, pentamidine, melarsoprol, eflornithine, and the combination of nifurtomox/eflornithine. Most of the drugs are old, having been discovered in the 1940s and 1950s, and have adverse effects such as nausea, vomiting, fatigue, seizures, fever, diarrhea, hypoglycemia, abdominal cramping, peripheral neuropathy, hypertension, heart damage, and neutropenia on the patients (Jacobs et al. 2011). For the reasons describe above, mining and developing new trypanosomiasis drugs from natural products is crucial and essential because endophytic fungi offer a high number of natural products with diverse chemical structures and novel pharmacological mechanism of action.
11.8.2 Leishmaniasis
Leishmaniasis is a group of human diseases caused by protozoan species of the genus Leishmania, which are prevalent in tropical and subtropical areas of the world. Brazil is among the ten countries affected by 90% of the cases worldwide of both cutaneous and visceral leishmaniasis (WHO 2010). More than one million people are being victimized by leishmaniasis worldwide, and reported fatalities are of around 30,000 annually (Kamhawi 2017). There are around 20 species of Leishmania (Trypanosomatidae), which can cause three variations of the leishmaniasis disease: cutaneous, mucocutaneous, or visceral leishmaniasis (Dawit et al. 2013).
Leishmania (Viannia) braziliensis is the main etiological agent of American tegumentary leishmaniasis and has the highest incidence in Brazil. This group of infectious diseases has different clinical forms that are associated with the molecular diversity of the parasite and host immune response (Pereira et al. 2017). The visceral manifestation of the disease is usually caused by Leishmania donovani and Leishmania infantum, and it can affect internal body organs. It is also popularly known as kala-azar and can be fatal (Clem 2010).
There is no vaccine to control these diseases (Dawit et al. 2013). The current therapy consists of sodium stibugluconate (Pentosam®), meglumine antimonate (Glucantime®), miltefosine, amphotericin B, and paromomycin. The first drugs used for treatment were the antimonials. However, in the 1970s, the parasites started to show resistance to pentavalent sodium antimony gluconate, even at high doses, and as a result, these drugs were mostly abandoned. Miltefosine has replaced antimonials as a treatment in cases of resistance. However, it has also been associated with increasing resistance. Treatment with amphotericin B is effective, but it has highly nephrotoxic effects. The treatment can also be inhibited by cost, access, and difficulties in obtaining oral formulations of the drug (Hefnawy et al. 2017). Thus, there is a need for the discovery of new leads or scaffolds that can be used to develop less toxic drugs and alternative oral treatments (Prates et al. 2017).
11.8.3 Trypanocidal and Leishmanicidal Compounds from Endophytic Fungi
The major bioactive metabolites obtained from endophytic fungi associated with medicinal plants presenting trypanocidal and leishmanicidal activities are listed in Table 11.6. The fungi obtained from the medicinal plant Caesalpinia echinata, popularly known as Brazilwood, were tested against L. amazonensis and T. cruzi. The isolates from Fusarium sp., Nectria mauritiicola, and Xylaria sp. were able to inhibit L. amazonensis growth, and the isolate from Fusarium sp. was able to inhibit T. cruzi growth. The ethyl acetate (EtOAc) of Fusarium sp. showed the most promising result by inhibiting 92% of T. cruzi growth at a dose of 20 μg mL−1. The extract of Fusarium sp. was subjected to fractionation, which revealed beauvericin as the active compound. While the crude extract of Fusarium sp. showed an IC50 of 30 μg mL−1 (2) in the assay with T. cruzi forms expressing the β-galactosidase gene, beauvericin showed an IC50 value times smaller (1.9 μg mL−1, 2.4 μM) (1). The EtOAc extract from the culture of Nectria pseudotrichia was active against amastigote-like forms of Leishmania (Leishmania) amazonensis showing an IC50 value of 4.6 μg mL−1 (2) (Campos et al. 2015). Fractionation of Nectria pseudotrichia extracts yielded seven compounds, 10-acetyl trichoderonic acid A (3), 6′-acetoxy-piliformic acid (4), 5′,6′-dehydropiliformic acid (5), piliformic acid (6), hydroheptelidic acid (7), xylaric acid D (8), and cytochalasin D (9). Compounds 3, 4, and 7 were the most active against Leishmania (Viannia) braziliensis, with IC50 values of 21.4, 28.3, and 24.8 μM, respectively, and showed low toxicity to Vero and THP-1 cells (Cota et al. 2018).
When screening for natural products with antiparasitic activity, the endophytic fungus, Microthyriaceae sp., was isolated from aboveground tissue of the tropical medicinal grass Paspalum conjugatum (Poaceae) in Panama. Cultivation followed by bioassay-guided chromatographic fractionation of the extract led to the isolation of the new polyketide integrasone B (9) and two known mycotoxins, sterigmatocystin (10) and secosterigmatocystin (11). Sterigmatocystin was found to be the main antiparasitic compound in the extract of fermentation broth of this fungus, possessing potent and selective antiparasitic activity against T. cruzi, with an IC50 value of 0.13 μmol L−1. Compounds 10 and 11 showed high cytotoxicity against Vero cells (IC50 of 0.1 and 1 μmol L−1 respectively) (Almeida et al. 2014).
The endophyte Lasiodiplodia theobromae obtained from the leaves of Vitex pinnata, a medicinal plant of Malaysia, displayed activity against Trypanosoma brucei brucei. Three known compounds were isolated, namely, cladospirone B (12), desmethyl-lasiodiplodin (13), and R-(−)-mellein (14). Cladospirone B and desmethyl-lasiodiplodin compounds exhibited good activity against T. b. brucei with minimum inhibitory concentrations of 17.8 μM and 22.5 μM, respectively (Kamal et al. 2016).
Brissow et al. (2018) demonstrated that crude EtOAc extracts of Diaporthe phaseolorum , an endophytic fungus isolated from the roots of Combretum lanceolatum Pohl ex Eichler, a Brazilian medicinal plant, showed trypanocidal activity at 20 μg mL−1, reducing 82% of the number of amastigotes and trypomastigotes of T. cruzi. The compound 18-des-hydroxy Cytochalasin H (15) was isolated and evaluated for leishmanicidal and tripanocidal activities. The compound reduced the viability of L. amazonenses promastigotes with an IC50 value of 9.2 μg mL−1.
From the endophytic fungus Aspergillus terreus isolated from roots of Carthamus lanatus L. (Asteraceae), one new butenolide derivative, Terrenolide S (16), together with six known compounds, (22E,24R)-stigmasta-5,7,22-trien-3-β-ol (17), stigmast-4-ene-3-one (18), stigmasta-4,6,8(14),22-tetraen-3-one (19), terretonin A (20), terretonin (21), and butyrolactone VI (22), has been isolated. Compounds 16, 17, and 18 exhibited antileishmanial activity toward L. donovani with IC50 values of 27.3, 15.3, and 11.2 μM, respectively, and IC90 values of 167, 40.6, and 14.7 μM, respectively (Elkhayata et al. 2015). The same kind of endophyte, the fungus Aspergillus terreus obtained from Hyptis suaveolens (L.) Poit, growing in the Brazilian wetland known as the Pantanal, showed trypanocidal and leishmanicidal activities. Three compounds were isolated from the acetate extract of the fungal culture: terrein (23), butyrolactone I (24), and butyrolactone V (25). Compounds 23, 24, and 25 exerted moderate leishmanicidal activity against L. amazonensis, IC50 = 23.7, 26.0, and 78.6 μM, respectively. Furthermore, compounds 24 and 25 were examined for the trypanocidal effect on L929 cells from mouse connective tissue infected with T. cruzi amastigotes and promastigotes. Both compounds were inactive or toxic. Compounds 24 and 25 killed 100% of the cells at 94.2 and 181.6 μM, respectively. It was the first report on the leishmanicidal activity of compounds 23, 24, and 25 against L. amazonensis (Silva et al. 2017c).
Carvalho et al. (2015) obtained the endophytic fungus Aspergillus calidoustus isolated from leaves of Acanthospermum australe (Asteraceae), a medicinal plant native to the Brazilian savannah. From this endophyte, they recovered two compounds, ophiobolin K (26) and 6-epi-ophiobolin K (27), which showed trypanocidal activities with IC50 values of 13.0 and 9.6 μM against T. cruzi. However, these compounds were also cytotoxic to the fibroblast host cells of T. cruzi.
Nascimento et al. (2015) reported that endophytes associated with the medicinal plant Vernonia polyanthes are a potential source of leishmanicidal compounds. They recovered 16 endophythes from leaves of this plant growing in Brazil, and the fungal culture crude ethanol extracts were tested for their antileishmanial activity. The most active extract was obtained from Cochliobolus sativus (IC50 = 3.0 μg mL−1). From this extract, a mixture of cochlioquinone A and isocochlioquinone A (28), and anhydrocochlioquinone A (29), was obtained. The mixture 28 exhibited a good antileishmanial activity, with an IC50 value of 10.2 μg mL−1. Anhydrocochlioquinone A also presented an antileishmanial activity, but its IC50 value was five times higher (50.5 μg mL−1).
11.9 Conclusion
Considering the high number of vegetal species living in the world, it is important to understand the methods and criteria to select the host plant for the study of endophyte communities in order to provide the best opportunities to isolate novel and potential endophytic fungi. Among the criteria used and described at the literature stands out the choice of medicinal plants (plants that have an ethnobotanical history), because that plants might be considered important reservoir of a promising source of novel endophytes and their compounds can be useful for human health and veterinary. The infectious/parasitic diseases and cancer, for example, discussed in this chapter still demand a special attention and need of investment in research considering the high mortality rate generated by some of them, together with the inexistence of an effective treatment without side effects and resistance. In this context, endophytic fungi are an alternative that might offer a high number of natural products with diverse chemical structures and novel pharmacological action’s mechanism. Endophytic taxa mainly of the genus Aspergillus, Chaetomium, Diaporthe/Phomopsis complex, Fusarium, and Penicillium are potential producers of bioactive compounds for the treatment of those diseases. Additionally, endophytes may contribute to their host plant and for the industry by producing a plethora of substances; however, the search for better treatments remains an important challenge and a constant niche to be explored.
References
Abu Bakar MF, Ahmad NE, Suleiman M, Rahmat A, Isha A (2015) Garcinia dulcis fruit extract induced cytotoxicity and apoptosis in HepG2 liver cancer cell line. Biomed Res Int:1–10
Ahmed I, Hussain H, Schulz B, Draeger S, Padula D, Pescitelli G, Krohn K (2011) Three new antimicrobial metabolites from the endophytic fungus Phomopsis sp. Eur J Org Chem 2011(15):2867–2873
Akay S, Ekiz G, Kocabaş F, Hameş-Kocabaş EE, Korkmaz KS, Bedir E (2014) A new 5,6-dihydro-2-pyrone derivative from Phomopsis amygdali, an endophytic fungus isolated from hazelnut (Corylus avellana). Phytochem Lett 7(1):93–96
Almeida C, Ortega H, Higgbotham S, Spadafora C, Arnold AE, Coley PD, Kursar TA, Gerwick WH, Cubilla-Rios L (2014) Chemical and bioactive natural products from Microthyriaceae sp., an endophytic fungus from a tropical grass. Lett Appl Microbiol 59:58–64
Alurappa R, Bojegowda MRM, Kumar V, Mallesh NK, Chowdappa S (2014) Characterisation and bioactivity of oosporein produced by endophytic fungus Cochliobolus kusanoi isolated from Nerium oleander L. Nat Prod Res 28(23):2217–2220
Aly AH, Debbab A, Kjer J, Proksch P (2010) Fungal endophytes from higher plants: a prolific source of phytochemicals and other bioactive natural products. Fungal Divers 41:1–16
Asker MMS, Mohamed SF, Mahmoud MG, El Sayed OH (2013) Antioxidant and antitumor activity of a new Sesquiterpene isolated from endophytic fungus Aspergillus glaucus. Int J PharmTech Res 5(2):391–397
Baker S, Satish S (2015) Endophytes: natural warehouse of bioactive compounds endophytes: natural warehouse of bioactive compounds. Drug Inven Today 4(11):548–553
Ballard CG (2002) Advances in the treatment of Alzheimer’s disease: benefits of dual cholinesterase inhibition. Eur Neurol 47:64–70
Baraban EG, Morin JB, Phillips GM, Phillips AJ, Strobel SA, Handelsman J (2013) Xyolide, a bioactive nonenolide from an Amazonian endophytic fungus, Xylaria feejeensis. Tetrahedron Lett 54(31):4058–4060
Bhagat J, Kaur A, Yadav AK, Sharma V, Chadha BS (2016) Cholinesterase inhibitor (Altenuene) from an endophytic fungus Alternaria alternate: optimization, purification and characterization. J Appl Microbiol 121:1015–1025
Bhagobaty RK, Joshi SR (2012) Antimicrobial and antioxidant activity of endophytic fungi isolated from ethnomedicinal plants of the “sacred forests” of Meghalaya, India. Mikologia Lekarska 19(1):5–11
de Borges W, Borges KB, Bonato PS, Said S, Pupo M (2009) Endophytic fungi: natural products, enzymes and biotransformation reactions. Curr Org Chem 13(12):1137–1163
Boucher HW, Talbot GH, Bradley JS, Edwards JEJ, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48(1):1–12
Brissow ER, Silva IP, Siqueira KP, Senabio JA, Pimenta LP, Januário AH, Magalhães LG, Furtado RA, Tavares DC, Junior PAS, Santos JL, Soares MA (2018) 18-Des-hydroxy Cytochalasin: an antiparasitic compound of Diaporthe phaseolorum-92C, an endophytic fungus isolated from Combretum lanceolatum Pohl ex Eichler. Parasitol Res 116(7):1823–1830
Budhiraja A, Nepali K, Sapra S, Gupta S, Kumar S, Dhar KL (2013) Bioactive metabolites from an endophytic fungus of Aspergillus species isolated from seeds of Gloriosa superba Linn. Med Chem Res 22(1):323–329
Bunyapaiboonsri T, Yoiprommarat S, Srikitikulchai P, Srichomthong K, Lumyong S (2010) Oblongolides from the endophytic fungus Phomopsis sp. BCC 9789. J Nat Prod 73(1):55–59
Campos FF, Sales PA Jr, Romanha AJ, Araújo MS, Siqueira EP, Resende JM, Alves TM, Martins-Filho OA, Santos VL, Rosa CA, Zani CL, Cota BB (2015) Bioactive endophytic fungi isolated from Caesalpinia echinata Lam. (Brazilwood) and identification of beauvericin as a trypanocidal metabolite from Fusarium sp. Mem Inst Oswaldo Cruz 110(1):65–74
Cao LL, Zhang YY, Liu YJ, Yang TT, Zhang JL, Zhang ZG, Shen L, Liu JY, Ye YH (2016) Anti-phytopathogenic activity of sporothriolide, a metabolite from endophyte Nodulisporium sp. A21 in Ginkgo biloba. Pestic Biochem Physiol 129:7–13
Carvalho CR, Vieira MLA, Cantrell CL, Wedge DE, Alves TMA, Zani CL, Pimenta RS, Junior PAS, Murta SMF, Romanha AJ, Rosa CA, Rosa LH (2015) Biological activities of ophiobolin K and 6-epi-ophiobolin K produced by the endophytic fungus Aspergillus calidoustus. Nat Prod Res 30(4):478–481
Carvalho CR, Wedge DE, Cantrell CL, Silva-Hughes AF, Pan Z, Moraes RM, Madoxx VL, Rosa LH (2016) Molecular phylogeny, diversity, and bioprospecting of endophytic fungi associated with wild ethnomedicinal North American plant Echinacea purpurea (Asteraceae). Chem Biodivers 13(7):918–930
Carvalho CR, Ferreira-D'Silva A, Wedge DE, Cantrell CL, Rosa LH (2018) Antifungal activities of cytochalasins produced by Diaporthe miriciae, an endophytic fungus associated with tropical medicinal plants. Can J Microbiol 64:835
Chandra S (2012) Endophytic fungi: novel sources of anticancer lead molecules. Appl Microbiol Biotechnol 95(1):47–59
Chapla VM, Zeraik ML, Leptokarydis IH, Silva GH, Bolzani VS, Young MCM, Pfenning LH, Araujo AR (2014a) Antifungal compounds produced by Colletotrichum gloeosporioides, an endophytic fungus from Michelia champaca. Molecules 19:19243–19252
Chapla VM, Zeraik ML, Ximenes VF, Zanardi LM, Lopes MN, Cavalheiro AJ, Silva DHS, Young MCM, da Fonseca LM, Bolzani VS, Araujo AR (2014b) Bioactive secondary metabolites from Phomopsis sp., an endophytic fungus from Senna spectabilis. Molecules 19:6597–6608
Chawla R, Arora R, Kumar R, Sharma A, Prasad J, Singh S, Sagar R, Chaudhary P, Shukla S, Kaur G, Sharma RK, Puri SC, Dhar KL, Handa G, Gupta VK, Qazi GN (2005) Antioxidant activity of fractionated extracts of rhizomes of high-altitude Podophyllum hexandrum: role in radiation protection. Mol Cell Biochem 273(1–2):193–208
Chen MJ, Fu YW, Zhou QY (2014) Penifupyrone, a new cytotoxic funicone derivative from the endophytic fungus Penicillium sp. HSZ-43. Nat Prod Res Taylor and Francis 28(19):1544–1548
Chen YM, Yang YH, Li XN, Zou C, Zhao PJ (2015) Diterpenoids from the endophytic fungus Botryosphaeria sp. P483 of the Chinese herbal medicine Huperzia serrata. Molecules 20:16924–16932
Cheng MJ, Wu MD, Yuan GF, Chen YL, Su YS, Hsieh MT, Chen IS (2012) Secondary metabolites and cytotoxic activities from the endophytic fungus Annulohypoxylon squamulosum. Phytochem Lett 5(1):219–223
Clem AA (2010) Current perspective on Leishmaniasis. J Global Infect Dis 2(2):124–126
Costa J, Peterson T (2012) Ecological niche modeling as a tool for understanding distributions and interactions of vectors, hosts and etiologic agents of Chagas disease. Editora Fiocruz, Rio de Janeiro, pp 59–70
Cota BB, Tunes LG, Maia DNB, Ramos JP, Djalma Menezes de Oliveira DM, Kohlhoff M, Alves TMA, Souza-Fagundes EM, Fernanda Fraga Campos FF, Zani CL (2018) Leishmanicidal compounds of Nectria pseudotrichia, an endophytic fungus isolated from the plant Caesalpinia echinata (Brazilwood). Mem Inst Oswaldo Cruz 113(2):102–110
Coura JR, Dias JCP (2009) Epidemiology, control and surveillance of Chagas disease – 100 years after its discovery. Men Inst Oswaldo Cruz 104(Suppl 1):31–40
Croft SL, Sundar S, Fairlamb AH (2006) Drug resistance in leishmaniasis. Clin Microbiol Rev 19:111–126
Dang L, Li G, Yang Z, Luo S, Zheng X, Zhang K (2010) Chemical constituents from the endophytic fungus Trichoderma ovalisporum isolated from Panax notoginseng. Ann Microbiol 60(2):317–320
Dawit G, Girma Z, Simenew K (2013) A review on biology, epidemiology and public health significance of Leishmaniasis. J Bacteriol Parasitol 4(2):166
Deshmukh SK, Mishra PD, Kulkarni-Almeida A, Verekar S, Sahoo MR, Periyasamy G, Goswami H, Khanna A, Balakrishnan A, Vishwakarma R (2009) Anti-inflammatory and anticancer activity of ergoflavin isolated from an endophytic fungus. Chem Biodivers 6(5):784–789
Devari S, Jaglan S, Kumar M, Deshidi R, Guru S, Bhushan S, Kushwaha M, Gupta AP, Gandhi SG, Sharma JP, Taneja SC, Vishwakarma RA, Shah BA (2014) Capsaicin production by Alternaria alternata, an endophytic fungus from Capsicum annum; LC-ESI-MS/MS analysis. Phytochemistry 98:183–189
Devi P, Rodrigues C, Naik CG, D’souza L (2012) Isolation and characterization of antibacterial compound from a mangrove-endophytic fungus, Penicillium chrysogenum MTCC 5108. Indian J Microbiol 52(4):617–623
Ding G, Song YC, Chen JR, Xu C, Ge HM, Wang XT, Tan RX (2006) Chaetoglobosin U, a cytochalasan alkaloid from endophytic Chaetomium globosum IFB-E019. J Nat Prod 69(2):302–304
Dong LH, Fan SW, Ling QZ, Huang BB, Wei ZJ (2014) Identification of huperzine A-producing endophytiv fungi isolated from Huperzia serrata. World J Microbiol Biotechnol 30:1011–1017
Duthey B (2013) Background paper 6.11 Alzheimer disease and other dementias
Elkhayata ES, Ibrahim SRM, Mohamedd GA, Rosse SA (2015) Terrenolide S, a new antileishmanial butenolide from the endophytic fungus Aspergillus terreus. Nat Prod Res 30(7):814–820
Eyberger AL, Dondapati R, Porter JR (2006) Endophyte fungal isolates from Podophyllum peltatum produce podophyllotoxin. J Nat Prod 69(8):1121–1124
Fuentefria AM, Pippi B, Dalla Lana DF, Donato KK, Andrade SF (2018) Antifungals discovery: an insight into new strategies to combat antifungal resistance. Lett Appl Microbiol 66(1):2–13
Gao N, Shang ZC, Yu P, Luo J, Jian KL, Kong LY, Yang MH (2017) Alkaloids from the endophytic fungus Penicillium brefeldianum and their cytotoxic activities. Chinese Chem Lett 28(6):1194–1199
Ge HM, Peng H, Guo ZK, Cul JT, Song YC, Tan RX (2010) Bioactive alkaloids from the plant endophytic fungus Aspergillus terreus. Planta Med 76:822–824
Giridharan P, Verekar SA, Khanna A, Mishra PD, Deshmukh SK (2012) Anticancer activity of sclerotiorin, isolated from an endophytic fungus Cephalotheca faveolata Yaguchi. Nishim and Udagawa Indian J Exp Biol 50(7):464–468
Goupil LS, McKerrow JH (2014) Introduction: drug discovery and development for neglected diseases. Chem Rev 114:11131–11137
Gowda HCH, Vasudeva R, Mathachen GP, Uma Shaanker R, Ganeshaiah KN (2002) Breeding types in Nothapodytes nimmoniana Graham: An important medicinal tree. Current Sci 83(9):9–10
Guedes PMM, Silva GK, Gutierrez FRS, Silva JS (2011) Current status of Chagas disease chemotherapy. Expert Rev Anti-Infect Ther 9(5):609–620
Guo B, Dai JR, Ng S, Huang Y, Leong C, Ong W, Carté BK (2000) Cytonic acids A and B: novel tridepside inhibitors of hCMV protease from the endophytic fungus Cytonaema species. J Nat Prod 63(5):602–604
Hefnawy A, Berg M, Dujardin JC, Muylder G (2017) Exploiting knowledge on Leishmania drug resistance to support the quest for new drugs. Trends Parasitol 33(3):162–174
Hoffman AM, Mayer SG, Strobel GA, Hess WM, Sovocool GW, Grange AH, Harper JK, Arif AM, Grant DM, Kelley EG (2008) Purification, identification and activity of Phomodione, a furandione from an endophytic Phoma species. Phytochemistry 69(4):1049–1056
Huang WY, Cai YZ, Hyde KD, Corke H, Sun M (2007) Endophytic fungi from Nerium oleander L. (Apocynaceae): main constituents and antioxidant activity. World J Microbiol Biotechnol 23:1253–1263
Huang YF, Zhao JL, Zhou LG, Wang MA, Wang JG, Li XL, Chen Q (2009) Antimicrobial compounds from the endophytic fungus Fusarium sp. Ppf4 isolated from the medicinal plant Paris polyphylla var. yunnanensis. Nat Prod Comm 4(11):1455–1458
Huang R, Xie XS, Fang XW, Ma KX, Wu SH (2015) Five new guaiane sesquiterpenes from the endophytic fungus Xylaria sp. YM 311647 of Azadirachta indica. Chem Biodivers 12(8):1281–1286
Hussain H, Jabeen F, Krohn K, Al-Harrasi A, Ahmad M, Mabood F, Shah A, Badshah A, Rehman NU, Green IR, Ali I, Draeger S, Schulz B (2014) Antimicrobial activity of two mellein derivatives isolated from an endophytic fungus. Med Chem Res 24:2111–2114
Hussain H, Root N, Jabeen F, Al-Harrasi A, Ahmad M, Mabood F, Hassan Z, Shah A, Green IR, Schulz B, Krohn K (2015) Microsphaerol and seimatorone: two new compounds isolated from the endophytic fungi, Microsphaeropsis sp. and Seimatosporium sp. Chem Biodivers 12:289–294
Ibrahim SRM, Elkhayat ES, Mohamed GA, Khedr AIM, Fouad MA, Kotb MHR, Ross SA (2015) Aspernolides F and G, new butyrolactones from the endophytic fungus Aspergillus terreus. Phytochem Lett 14:84–90
Ibrahim SRM, Elkhayat ES, Mohamed GAA, Fat’hi SM, Ross SA (2016) Fusarithioamide A, a new antimicrobial and cytotoxic benzamide derivative from the endophytic fungus Fusarium chlamydosporium. Biochem Biophys Res Commun 479:211–216
Ibrahim SRM, Abdallah HM, Elkhayat ES, Al Musayeib NM, Asfour HZ, Zayed MF, Mohamed GA (2018) Fusaripeptide a: new antifungal and anti-malarial cyclodepsipeptide from the endophytic fungus Fusarium sp. J Asian Nat Prod Res 20(1):75–85
Isaka M, Berkaew P, Intereya K, Komwijit S, Sathitkunanon T (2007) Antiplasmodial and antiviral cyclohexadepsipeptides from the endophytic fungus Pullularia sp. BCC 8613. Tetrahedron 63(29):6855–6860
Isaka M, Chinthanom P, Boonruangprapa T, Rungjindamai N, Pinruan U (2010) Eremophilane-type Sesquiterpenes from the fungus Xylaria sp. BCC 21097. J Nat Prod 73(4):683–687
Jacobs RT, Nare B, Phillips MA (2011) State of the art in African trypanosome drug discovery. Curr Top Med Chem 11:1255
Jayanthi G, Kamalraj S, Karthikeyan K, Muthumary J (2011) Antimicrobial and antioxidant activity of the endophytic fungus Phomopsis sp. GJJM07 isolated from Mesua ferrea. Int J Curr Sci 1:85–90
Jia M, Chen L, Xin H, Zheng C, Rahman K, Han T, Qin L (2016) A friendly relationship between endophytic fungi and medicinal plants: a systematic review. Front Microbiol 7:906
Johann S, Rosa LH, Rosa CA, Perez P, Cisalpino PS, Zani CL, Cota BB (2012) Antifungal activity of altenusin isolated from the endophytic fungus Alternaria sp. against the pathogenic fungus Paracoccidioides brasiliensis. Rev Iberoam Micol 29(4):205–209
Kajula M, Ward JM, Turpeinen A, Tejesvi MV, Hokkanen J, Tolonen A, Hakkanen H, Picart P, Ihalainen J, Sahl HG, Pirttilä AM, Mattila S (2016) Bridged Epipolythiodiketopiperazines from Penicillium raciborskii, an endophytic fungus of Rhododendron tomentosum Harmaja. J Nat Prod 79(4):685–690
Kamal N, Viegelmann CV, Clements CJ, Edrada-Ebe R (2016) Metabolomics-guided isolation of anti-trypanosomal metabolites from the endophytic fungus Lasiodiplodia theobromae. Planta Med 83(6):565–573
Kamhawi S (2017) The yin and yang of leishmaniasis control. PLoS Neglect Trop Dis 11(4):e0005529
Kasaei A, Mobini-Dehkordi M, Mahjoubi F, Saffar B (2017) Isolation of Taxol-producing endophytic fungi from Iranian yew through novel molecular approach and their effects on human breast cancer cell line. Curr Microbiol Springer US 74(6):702–709
Kaul S, Gupta S, Ahmed M, Dhar MK (2012) Endophytic fungi from medicinal plants: a treasure hunt for bioactive metabolites. Phytochem Rev 11(4):487–505
Khan N, Tamboli ET, Sharma VK, Kumar S (2013) Phytochemical and pharmacological aspects of Nothapodytes nimmoniana. An overview. Herba Pol 59(1)
Khan AL, Ali L, Hussain J, Rizvi TS, Al-Harrasi A, Lee IJ (2015) Enzyme inhibitory Radicinol derivate from endophytic fungus Bipolaris sorokiniana LK12, associated with Rhayza stricta. Molecules 20:12198–12208
Khan AL, Gilani SA, Waqas M, Al-Hosni K, Al-Khiziri S, Kim YH, Ali L, Kang S, Asaf S, Shahzad R, Hussain J, Lee I, Al-Harrasi A (2017) Endophytes from medicinal plants and their potential for producing indole acetic acid, improving seed germination and mitigating oxidative stress. J Zhejiang Univ-Sci B (Biomed Biotechnol) 18(2):125–137
Kharwar RN, Verma VC, Kumar A, Gond SK, Harper JK, Hess WM, Lobkovosky E, Ma C, Ren YH, Strobel GA (2009) Javanicin, an antibacterial naphthaquinone from an endophytic fungus of Neem, Chloridium sp. Curr Microbiol 58(3):233–238
Khiralla A, Mohamed I, Thomas J, Mignard B, Spina R, Yagi S, Laurain-Mattar D (2015) A pilot study of antioxidant potential of endophytic fungi from some Sudanese medicinal plants. Asian Pac J Trop Med 8(9):701–704
Kjer J, Wray V, Edrada-Ebel R, Ebel R, Pretsch A, Lin W, Proksch P (2009) Xanalteric acids I and II and related phenolic compounds from an endophytic Alternaria sp. isolated from the mangrove plant Sonneratia alba. J Nat Prod 72(11):2053–2057
Kour A, Shawl AS, Rehman S, Sultan P, Qazi PH, Suden P, Khajuria RK, Verma V (2008) Isolation and identification of an endophytic strain of Fusarium oxysporum producing podophyllotoxin from Juniperus recurva. World J Microbiol Biotechnol 24(7):1115–11121
Krishnaiah D, Devi T, Bono A, Sarbatly R (2009) Studies on phytochemical constituents of six Malaysian medicinal plants. J Med Plants Res 3(2):67–72
Kumar A, Patil D, Rajamohanan PR, Ahmad A (2013) Isolation, purification and characterization of vinblastine and vincristine from endophytic fungus Fusarium oxysporum isolated from Catharanthus roseus. PLoS One 8(9):e71805
Kumar S, Aharwal RP, Shukla H, Rajak RC, Sandhu SS (2014) Endophytic fungi: as a source of antimicrobials bioactive compounds. World J Pharm Pharm Sci 3(2):1179–1197
Kusari S, Zühlke S, Spiteller M (2009) An endophytic fungus from Camptotheca acuminata that produces camptothecin and analogues. J Nat Prod 72(1):2–7
Kusari S, Hertweck C, Spiteller M (2012) Chemical ecology of endophytic fungi: origins of secondary metabolites. Chem Biol 19(7):792–798
Kyekyeku JO, Kusari S, Adosraku RK, Bullach A, Golz C, Strohmann C, Spiteller M (2017) Antibacterial secondary metabolites from an endophytic fungus, Fusarium solani JK10. Fitoterapia 119:108–114
Lai D, Wang A, Cao Y, Zhou K, Mao Z, Dong X, Tian J, Xu D, Dai J, Peng Y, Zhou K, Liu Y (2016) Bioactive Dibenzo-α-pyrone derivatives from the endophytic fungus Rhizopycnis vagum Nitaf22. J Nat Prod 79:2022–2031
Lenzi J, Costa TM, Alberton MD, Goulart JAG (2018) Medicinal fungi: a source of antiparasitic secondary metabolites. Appl Microbiol Biotechnol 102(14):5791–5810
Li R, Chen S, Niu S, Guo L, Yin J, Che Y (2014) Exserolides A-F, new isocoumarin derivatives from the plant endophytic fungus Exserohilum sp. Fitoterapia 96:88–94
Li G, Kusari S, Kusari P, Kayser O, Spiteller M (2015a) Endophytic Diaporthe sp. LG23 produces a potent antibacterial tetracyclic triterpenoid. J Nat Prod 78(8):2128–2132
Li TX, Yang MH, Wang XB, Wang Y, Kong LY (2015b) Synergistic antifungal meroterpenes and dioxolanone derivatives from the endophytic fungus Guignardia sp. J Nat Prod 78:2511–2520
Li W, Yang X, Yang Y, Duang R, Chen G, Li X, Li Q, Qin S, Li S, Zhao L, Ding Z (2016a) Anti-phytopathogen, multi-target acetylcholinesterase inhibitory and antioxidant activities of metabolites from endophytic Chaetomium globosum. Nat Prod Res 30(22):2616–2619
Li W, Xu J, Li F, Xu L, Li C (2016b) A new antifungal isocoumarin from the endophytic fungus Trichoderma sp. 09 of Myoporum bontioides A. Gray Pharmacogn Mag 12(48):259–261
Li G, Kusari S, Golz C, Laatsch H, Strohmann C, Spiteller M (2017) Epigenetic modulation of endophytic Eupenicillium sp. LG41 by a histone deacetylase inhibitor for production of Decalin-containing compounds. J Nat Prod 80(4):983–988
Liang XA, Ma YM, Zhang HC, Liu R (2016) A new helvolic acid derivative from an endophytic Fusarium sp. of Ficus carica. Nat Prod Res 30:2407–2412
Lin X, Lu C, Huang Y, Zheng Z, Su W, Shen Y (2007) Endophytic fungi from a pharmaceutical plant, Camptotheca acuminata: isolation, identification and bioactivity. World J Microbiol Biotechnol 23(7):1037–1040
Lin T, Wang G, Zeng D, Chen H (2015) Cytotoxic metabolites from Botryotinia fuckeliana A-S-3: an endophytic fungus from Ajuga decumbens. Phytochem Lett 13:206–211
Liu X, Dong M, Chen X, Jiang M, Lv X, Zhou J (2008) Antimicrobial activity of an endophytic Xylaria sp. YX-28 and identification of its antimicrobial compound 7-amino-4-methylcoumarin. Appl Microbiol Biotechnol 78(2):241–247
Liu S, Liu X, Guo L, Che Y, Liu L (2013) 2H-Pyran-2-one and2H-Furan-2-one derivatives from the plant endophytic fungus Pestalotiopsis fici. Chem Biodivers 10:2007–2013
Liu K, Yang YB, Chen JL, Miao CP, Wang Q, Zhou H, Chen YW, Li YQ, Ding ZT, Zhao LX (2016a) Koninginins N-Q, polyketides from the endophytic fungus Trichoderma koningiopsis harbored in Panax notoginseng. Nat Prod Bioprospect 6:49–55
Liu K, Yang Y, Miao CP, Zheng YK, Chen JL, Chen YW, Xu LH, Guang HL, Ding ZT, Zhao LX (2016b) Koningiopisins A-H, polyketides with synergistic antifungal activities from the endophytic fungus Trichoderma koningiopsis. Planta Med 82:371–376
Ma YM, Qiao K, Kong Y, Li MY, Guo LX, Miao Z, Fan C (2017) A new isoquinolone alkaloid from an endophytic fungus R22 of Nerium indicum. Nat Prod Res 31(8):1–8
Mahadevan S, Park Y (2008) Multifaceted therapeutic benefits of Ginkgo biloba L.: chemistry, efficacy, safety, and uses. J Food Sci 73(1)
Manju K, Jat RK, Anju G (2012) A review on medicinal plants used as a source of anticancer agents. Int J Drug Res Technol 2(3):177–183
Martínez-Luis S, Cherigo L, Higginbotham S, Arnold E, Spadafora C, Ibañez A, Gerwick WH, Cubilla-Rios L (2011) Screening and evaluation of antiparasitic and in vitro anticancer activities of Panamanian endophytic fungi. Int Microbiol 14(2):95–102
McCune LM, Johns T (2002) Antioxidant activity in medicinal plants associated with the symptoms of diabetes mellitus used by the indigenous peoples of the North American boreal forest. J Ethnopharmacol 82(2–3):197–205
Meng X, Mao Z, Lou J, Xu L, Zhong L, Peng Y, Zhou L, Wang M (2012) Benzopyranones from the endophytic fungus Hyalodendriella sp. Ponipodef12 and their bioactivities. Molecules 17:11303–11314
Mondol MAM, Farthouse J, Islam MT, Schueffler A, Laatsch H (2017) Metabolites from the endophytic fungus Curvularia sp. M12 act as motility inhibitors against Phytophthora capsici zoospores. J Nat Prod 80:347–355
Mousa WK, Schwan A, Davidson J, Auzanneau FI, Strange P, Liu H, Zhou T, Raizada MN (2015) An endophytic fungus isolated from finger millet (Eleusine coracana) produces anti-fungal natural products. Front Microbiol 6:1–16
Mousa WK, Schwan AL, Raizada MN (2016) Characterization of antifungal natural products isolated from endophytic fungi of finger millet (Eleusine coracana). Molecules 21:1171
Muelas-Serrano S, Le-Senne A, Fernandez-Portillo C, Nogal JJ, Ochoa C, Gomez-Barrio A (2002) In vitro and in vivo anti-Trypanosoma cruzi activity of a novel nitro-derivative. Mem Inst Oswaldo Cruz 97:553–557
Na R, Jiajia L, Dongliang Y, Yingzi P, Juan H, Xiong L, Nana Z, Yitian L (2016) Identification of vincamine indole alkaloids producing endophytic fungi isolated from Nerium indicum, Apocynaceae. Microbiol Res 192:114–121
Nadeem M (2012) Fusarium solani, P1, a new endophytic podophyllotoxin-producing fungus from roots of Podophyllum hexandrum. African J Microbiol Res 6(10):2493–2499
Naik GH, Pryadarsini KI, Satav JG, Banavalikar MM, Shohoni MK, Biyani MK, Mohan H (2003) Comparative antioxidant activity of individual herbal components used in Aryurvedic medicine. Phytochemistry 63:97–104
Nalli Y, Mirza DN, Wani ZA, Wadhwa B, Mallik FA, Raina C, Chaubey A, Riyaz-Ul-Hassan S, Ali A (2015) Phialomustin A-D, new antimicrobial and cytotoxic metabolites from an endophytic fungus, Phialophora mustea. RSC Adv 5:95307–95312
Nascimento AM, Soares MG, Torchelsen FKVS, Araujo JAV, Lage PS, Duarte MC, Andrade PHR, Ribeiro TG, Coelho EAF, Nascimento AM (2015) Antileishmanial activity of compounds produced by endophytic fungi derived from medicinal plant Vernonia polyanthes and their potential as source of bioactive substances. World J Microbiol Biotechnol 31(11):1793–1800
Nath A, Raghunatha P, Joshi SR (2012) Diversity and biological activities of endophytic fungi of Embilica officinalis, an Ehnomedicinal Plant of India. Mycobiology 40(1):8–13
Nath A, Chattopadhyay A, Joshi SR (2013) Biological activity of endophytic fungi of Rauwolfia serpentina Benth: an ethnomedicinal plant used in folk medicines. Natl Acad Sci 85(1):233–240
Nisa H, Kamili AN, Nawchoo IA, Shafi S, Shameem N, Bandh SA (2015) Fungal endophytes as prolific source of phytochemicals and other bioactive natural products: a review. Microb Pathog 82:50–59
Oliveira CM, Regasini LO, Silva GH, Pfenning LH, Young MCM, Berlinck RGS, Bolzani VS, Araujo AR (2011) Dihydroisocoumarins produced by Xylaria sp. and Penicillium sp., endophytic fungi associated with Piper aduncun and Alibertia macrophylla. Phytochem Lett 4(2):93–96
OPAS - OMS. OMS divulga lista de doenças prioritárias para pesquisa e desenvolvimento em 2018 [Internet]. ONU Bras. 2018 [cited 2018 July 18]. Available from: https://www.paho.org/bra/index.php?option=com_content&view=article&id=5595:oms-divulga-lista-de-doencas-e-patogenos-prioritarios-para-pesquisa-e-desenvolvimento-em-2018&Itemid=812
OPAS/OMS. OMS: câncer mata 8,8 milhões de pessoas anualmente no mundo [Internet]. ONU Bras. 2017 [cited 2018 July 18]. p. 1. Available from: https://nacoesunidas.org/oms-cancer-mata-88-milhoes-de-pessoas-anualmente-no-mundo/
OuYang XK, Jin MC, He CH (2007) Preparative separation of four major alkaloids from medicinal plant of Tripterygium Wilfordii Hook F using high-speed counter-current chromatography. Sep Purif Technol 56(3):319–324
Pamphile JA, Costa AT, Rosseto P, Polonio C, Pereira JO, Azevedo JL (2017) Aplicações biotecnológicas de metabólitos secundários extraídos de fungos endofíticos: o caso do Colletotrichum sp. Rev Uningá 53(1):113–119
Pandi M, Kumaran RS, Choi YK, Kim HJ, Muthumary J (2011) Isolation and detection of taxol, an anticancer drug produced from Lasiodiplodia theobromae, an endophytic fungus of the medicinal plant Morinda citrifolia. African J Biotechnol 10(8):1428–1435
Pereira CB, de Oliveira DM, Hughes AFS, Kohlhoff M, Vieira MLA, Martins Vaz AB, Ferreira MC, Carvalho CR, Rosa LH, Rosa CA, Alves TMA, Zani CL, Johann S, Cota BB (2015) Endophytic fungal compounds active against Cryptococcus neoformans and C. gattii. J Antibiot 68(7):436–444
Pereira LO, Moreira RB, de Oliveira MP, Reis SO, de Oliveira Neto MP, Pirmez C (2017) Is Leishmania (Viannia) braziliensis parasite load associated with disease pathogenesis? Int J Infect Dis 57:132–137
Perveen I, Raza MA, Iqbal T, Naz I, Sehar S, Ahmed S (2017) Isolation of anticancer and antimicrobial metabolites from Epicoccum nigrum; endophyte of Ferula sumbul. Microb Pathogenesis 110:214–224
Phaopongthai J, Wiyakrutta S, Meksuriyen D, Sriubolmas N, Suwanborirux K (2013) Azole-synergistic anti-candidal activity of altenusin, a biphenyl metabolite of the endophytic fungus Alternaria alternate isolated from Terminalia chebula Retz. J Microbiol 51(6):821–828
Pongcharoen W, Rukachaisirikul V, Phongpaichit S, Rungjindarnai N, Sakayaroj J (2006) Pimarane diterpene and cytochalasin derivatives from the endophytic fungus Eutypella scoparia PSU-D44. J Nat Prod 69(5):856–858
Prates FV, Dourado ME, Silva SC, Schriefer A, Guimarães LH, Brito MD, Almeida J, Carvalho EM, Machado PR (2017) Fluconazole in the treatment of cutaneous Leishmaniasis caused by Leishmania braziliensis: a randomized controlled trial. Clin Infect Dis 64(1):67–71
Prince M, Comas-Herrera A, Knapp M, Guerchet M, Karagiannidou M (2016) World Alzheimer report 2016 improving healthcare for people living with dementia. Alzheimer’s Disease International, London
Puri SG, Verma V, Amna T, Qazi GN, Spiteller M (2005) An endophytic fungus from Nothapodytes foetida that produces camptothecin. J Nat Prod 68(12):1717–1719
Puri SC, Nazir A, Chawla R, Arora R, Riyaz-Ul-Hasan S, Amna T, Ahmed B, Verma V, Singh S, Sagar R, Sharma A, Kumar R, Sharma RK, Qazi GN (2006) The endophytic fungus Trametes hirsuta as a novel alternative source of podophyllotoxin and related aryl tetralin lignans. J Biotechnol 122(4):494–510
Qiao W, Ling F, Yu L, Huang Y, Wang T (2017) Enhancing taxol production in a novel endophytic fungus, Aspergillus aculeatinus Tax-6, isolated from Taxus chinensis var. mairei. Fungal Biol 121(12):1037–1044
Qin S, Krohn K, Hussain H, Schulz B, Draeger S (2011) Pestalotheols E–H: antimicrobial metabolites from an endophytic fungus isolated from the tree Arbutus unedo. Eur J Org Chem 2011(26):5163–5166
Qiu M, Xie RS, Shi Y, Zhang H, Chen H (2010) Isolation and identification of two flavonoid-producing endophytic fungi from Ginkgo biloba L. Ann Microbiol 60:143–150. (FORA DA ORDEM ALFABÉTICA NA LISTA)
Radić N, Štrukelj B (2012) Endophytic fungi - the treasure chest of tibacterial substances. Phytomedicine 19(14):1270–1284
Ran X, Zhang G, Li S, Wang J (2017) Characterization and antitumor activity of camptothecin from endophytic fungus Fusarium solani isolated from Camptotheca acuminate. Afr Health Sci 17(2):566–574
Rana KL, Kour D, Sheikh I, Yadav N, Yadav AN, Kumar V, Singh BP, Dhaliwal HS, Saxena AK (2018a) Biodiversity of endophytic fungi from diverse niches and their biotechnological applications. In: Singh BP (ed) Advances in endophytic fungal research. Springer, Switzerland. https://doi.org/10.1007/978-3-030-03589-1_6
Rana KL, Kour D, Yadav AN (2018b) Endophytic microbiomes: biodiversity, ecological significance and biotechnological applications. Res J Biotechnol 14:1–30
Rao HCY, Satish S (2015) Genomic and chromatographic approach for the discovery of polyketide antimicrobial metabolites from an endophytic Phomopsis liquidambaris CBR-18. Front Life Sci 8(2):200–207
Roome T, Dar A, Ali S, Naqvi S, Choudhary MI (2008) A study on antioxidant, free radical scavenging, anti-inflammatory and hepatoprotective actions of Aegiceras corniculatum (stem) extracts. J Ethnopharmacol 118(3):514–521
Schulze CJ, Donia MS, Siqueira-Neto JL, Ray D, Raskatov JA, Green RE, McKerrow JH, Fischbach MA, Linington RG (2015) Genome-directed Lead discovery: biosynthesis, structure elucidation, and biological evaluation of two families of polyene macrolactams against Trypanosoma Brucei. ACS Chem Biol 10:2373–2381
Scotti L, Ferreira EI, Da Silva MS, Scotti MT (2010) Chemometric studies on natural products as potential inhibitors of the NADH oxidase from Trypanosoma cruzi using the VolSurf approach. Molecules 15(10):7363–7377
Selim KA, El-Beih AA, Abdel-Rahman TM, El-Diwany AI (2014) Biological evaluation of endophytic fungus, Chaetomium globosum JN711454, as potential candidate for improving drug discovery. Cell Biochem Biophys 68:67–82
Shan T, Tian J, Wang X, Mou Y, Mao Z, Lai D, Dai J, Peng Y, Zhou L, Wang M (2014) Bioactive spirobisnaphthalenes from the endophytic fungus Berkleasmium sp. J Nat Prod 77(10):2151–2160
Shentu X, Zhan X, Ma Z, Yu X, Zhang C (2014) Antifungal activity of metabolites of the endophytic fungus Trichoderma brevicompactum from garlic. Braz J Microbiol 45(1):248–254
Shukla ST, Kulkarni VH, Habbu PV, Jagadeesh KS, Patil BS, Smita DM (2012) Hepatoprotective and antioxidant activities of crude fractions of endophytic fungi of Ocimum sanctum Linn. in rats. Orient Pharm Exp Med 12:81–91
Silva GH, Zeraik ML, de Oliveira CM, Teles HL, Trevisan HC, Pfenning LH, Nicolli CP, Young MCM, Mascarenhas YP, Abreu LM, Saraiva AC, Medeiros AI, Bolzani VS, Araujo AR (2017a) Lactone derivatives produced by a Phaeoacremonium sp., an endophytic fungus from Senna spectabilis. J Nat Prod 80(5):1674–1678
Silva CG, De Almeida VL, Rodrigues P (2017b) Plant cell cultures as producers of secondary metabolites: podophyllum lignans as a model. In: Transgenesis and secondary metabolism (Rd. Jha S). Springer, pp 67–102
Silva IP, Brissow E, Filho LCK, Senabio J, Siqueira KA, Filho SV, Damasceno JL, Mendes AS, Tavares DC, Magalhães LD, Junior PAS, Ana Helena Januário AH, Soares MA (2017c) Bioactive compounds of Aspergillus terreus—F7, an endophytic fungus from Hyptis suaveolens (L.) Poit. World J Microbiol Biotechnol 33:62
Silva-Hughes AF, Carvalho CR, Wedge DE, Cantrell CL, Pan Z, Moraes RM, Madoxx VL, Rosa LH (2015) Diversity and antifungal activity of the endophytic fungi associated with the native medicinal cactus Opuntia humifusa (Cactaceae) from the United States. Microbiol Res 175:67–77
Simarro PP, Diarra A, Postigo JAR, Franco JR, Jannin JG (2011) The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000–2009: the way forward. PLoS Negl Trop Dis 5(2):e1007
Singh SB, Ondeyka JG, Tsipouras N, Ruby C, Sardana V, Schulman M, Sanchez M, Pelaez F, Stahlhut MW, Munshi S, Olsen DB, Lingham RB (2004) Hinnuliquinone, a C2-symmetric dimeric non-peptide fungal metabolite inhibitor of HIV-1 protease. Biochem Biophys Res Commun 324(1):108–113
Singh B, Thakur A, Kaur S, Chadha BS, Kaur A (2012) Acetylcholinesterase inhibitory potential and Inseticidal activity of an endophytic Alternaria sp. Appl Biochem Biotechnol 168:991–1002
Singh B, Sharma P, Kumar A, Chadha P, Kaur R, Kaur A (2016) Antioxidant and in vivo genoprotective effects of phenolic compounds identified from na endophytic Cladosporium velox and their relationship with its host plant Tinospora cordifolia. J Ethnopharmacol 194:450–456
Siriwach R, Kinoshita H, Kitani S, Igarashi Y, Pansuksan K, Panbangred W, Nihira T (2014) Bipolamides a and B, triene amides isolated from the endophytic fungus Bipolaris sp. MU34. J Antibiot 67:167–170
Srinivasan K, Jagadish LK, Shenbhagaraman R, Muthumary J (2010) Antioxidant activity of endophytic fungus Phyllosticta sp. isolated from Guazuma tomentosa. J Phytology 2(6):37–41
Stierle A, Strobel G, Stierle D, Grothaus P, Bignami G (1995) The 25 search for a taxol-producing microorganism among the endophytic fungi of the pacific yew, Taxus brevifolia. J Nat Prod 58:1315–1324
Strobel G (2003) Endophytes as sources of bioactive products. Microb Infect 5:535–544
Strobel G, Daisy B (2003) Bioprospecting for microbial endophytes and their natural product. Microbiol Mol Biol Rev 67(4):491–502
Strobel G, Daisy B, Castillo U, Harper J (2004) Natural products from endophytic microorganisms. J Nat Prod 67:257–268
Su H, Kang JC, Cao JJ, Mo L, Hyde KD (2014) Medicinal plant endophytes produce analogous bioactive compounds. Chiang Mai J Sci 41(1):1–13
Subban K, Subramani R, Muthumary J (2013) A novel antibacterial and antifungal phenolic compound from the endophytic fungus Pestalotiopsis mangiferae. Nat Prod Res 27(16):1445–1449
Suman A, Yadav AN, Verma P (2016) Endophytic microbes in crops: diversity and beneficial impact for sustainable agriculture. In: Singh D, Abhilash P, Prabha R (eds) Microbial inoculants in sustainable agricultural productivity, research perspectives. Springer, India, pp 117–143. https://doi.org/10.1007/978-81-322-2647-5_7
Sun ZL, Zhang M, Zhang JF, Feng J (2011) Antifungal and cytotoxic activities of the secondary metabolites from endophytic fungus Massrison sp. Phytomedicine 18(10):859–862
Sun P, Huo J, Kurtan T, Mandi A, Antus S, Tang H, Draeger S, Schulz B, Hussain H, Krohn K, Pan W, Yi Y, Zhang W (2013) Structural and stereochemical studies of hydroxyanthraquinone derivatives from the endophytic fungus Coniothyrium sp. Chirality 25:141–148
Talontsi FM, Dittrich B, Schueffler A, Sun H, Laatsch H (2013) Epicoccolides: antimicrobial and antifungal polyketides from an endophytic fungus Epicoccum sp. associated with Theobroma cacao. Eur J Org Chem 2013:3174–3180
Tanney JB, McMullin DR, Green BD, Miller JD, Seifert KA (2016) Production of antifungal and anti-insectan metabolites by the Picea endophyte Diaporthe maritima sp. nov. Fungal Biol 120(11):1448–1457
Taware R, Abnave P, Patil D, Rajamohananan PR, Raja R, Soundararajan G, Kundu GC, Ahmad A (2014) Isolation, purification and characterization of Trichothecinol-A produced by endophytic fungus Trichothecium sp. and its antifungal, anticancer and antimetastatic activities. Sustain Chem Process 2:8
Tawfik N, Tawfike ŮA, Abdo R, Abbott G, Abdelmohsen UR, Edrada-Ebel R, Haggag E (2017) Metabolomics and bioactivity guided isolation of secondary metabolites from the endophytic fungus Chaetomium sp. J Adv Pharmacy Res 1(1):66–74
Tayung K, Barik BP, Jha DK, Deka DC (2011) Identification and characterization of antimicrobial metabolite from an endophytic fungus, Fusarium solani isolated from bark of Himalayan yew. Mycosphere 2(3):203–213
Tejesvi MV, Kini KR, Prakash HS, Subbiah V, Shetty HS (2008) Antioxidant, antihypertensive, and antibacterial properties of endophytic Pestalotiopsis species from medicinal plants. Can J Microbiol 54:769–780
Ugurlu E, Secmen O (2008) Medicinal plants popularly used in the villages of Yunt Mountain(Manisa-Turkey). Fitoterapia 79(2):126–131
Vallabhaneni S, Mody RK, Walker T, Chiller T (2015) The global burden of fungal diseases. Infect Dis Clin N Am 30(1):1–11
Van Goietsenoven G, Mathieu V, Andolfi A, Cimmino A, Lefranc F, Kiss R, Evidente A (2011) In vitro growth inhibitory effects of cytochalasins and derivatives in cancer cells. Planta Med 77(7):711–717
Vazquez BP, Vazquez TP, Miguel CB, Rodrigues WF, Mendes MT, Oliveira CJF, Chica JEL (2015) Inflammatory responses and intestinal injury development during acute Trypanosoma cruzi infection are associated with the parasite load. Parasit Vectors 8:206
Verekar S, Nutrisciences M, Deshmukh S, Energy T (2017) Isolation, characterization of endophytic fungi of Mimusops elengi (Bakul). Mycol Soc India 48:21–25
Wagenaar MM, Corwin J, Strobel G, Clardy J (2000) Three new cytochalasins produced by an endophytic fungus in the genus Rhinocladiella. J Nat Prod 63(12):1692–1695
Wang Y, Xu L, Ren W, Zhao D, Zhu Y, Wu X (2012) Bioactive metabolites from Chaetomium globosum L18, an endophytic fungus in the medicinal plant Curcuma wenyujin. Phytomedicine 19(3–4):364–368
Wang J, Zhang YY, Ding DD, Yu SP, Wang LW (2013) A study on the secondary metabolites of endophytic fungus Chaetomium cupreum ZJWCF079 in Macleaya cordata. Health Res 33:94–96
Wang J, Wang G, Zhang Y, Zheng B, Zhang C, Wang L (2014) Isolation and identification of an endophytic fungus Pezicula sp. in Forsythia viridissima and its secondary metabolites. World J Microbiol Biotechnol 30:2639–2644
Wang WX, Kusari S, Laatsch H, Golz C, Kusari P, Strohmann C, Spiteller M (2016a) Antibacterial azaphilones from an endophytic fungus, Colletotrichum sp. BS4. J Nat Prod 79(4):704–710
Wang Y, Lai Z, Li XX, Yan RM, Zhang ZB, Yang HL, Zhu D (2016b) Isolation, diversity and acetylcholinesterase inhibitory activity of the culturable endophytic fungi harboured in Huperzia serrata from Jinggang Mountain. China World J Microbiol Biotechnol 32(2):20
Weinstock M (1999) Selectivity of cholinesterase Ihibition: clinical implications for the treatment of Alzheimer’s disease. CNS Drugs 12(4):307–323
World Health Organization (WHO) (2010) Control of leishmaniases. Technical Report Series
World Health Organization (WHO) (2014) Chagas disease (American trypanosomiasis)
World Health Organization (WHO) (2017) Chagas disease (American trypanosomiasis)
Wu SH, Huang R, Miao CP, Chen YW (2013a) Two new steroids from an endophytic fungus Phomopsis sp. Chem Biodivers 10:1276–1283
Wu LS, Hu CL, Han T, Zheng CJ, Ma XQ, Rahman K, Qin LP (2013b) Cytotoxic metabolites from Perenniporia tephropora, an endophytic fungus from Taxus chinensis var. mairei. Appl Microbiol Biotechnol 97(1):305–315
Wu SH, He J, Li XN, Huang R, Song F, Chen YW, Miao CP (2014) Guaiane sesquiterpenes and isopimarane diterpenes from an endophytic fungus Xylaria sp. Phytochemistry 105:197–204
Wu LS, Jia M, Chen L, Zhu B, Dong HX, Si JP, PengW HT (2016) Cytotoxic and antifungal constituents isolated from the metabolites of endophytic fungus DO14 from Dendrobium officinale. Molecules 21:1–14
Wu X, Pang XJ, Xu LL, Zhao T, Long XY, Zhang QY, Qin HL, Yang DF, Yang XL (2017) Two new alkylated furan derivatives with antifungal and antibacterial activities from the plant endophytic fungus Emericella sp. XL029. Nat Prod Res:1–7
Wu YY, Zhang TY, Zhang MY, Cheng J, Zhang YX (2018) An endophytic fungi of Ginkgo biloba L. produces antimicrobial metabolites as potential inhibitors of FtsZ of Staphylococcus aureus. Fitoterapia 128:265–271
Xiao Y, Li H, Li C, Wang J, Li J, Wang M, Ye Y (2013) Antifungal screening of endophytic fungi from Ginkgo biloba for discovery of potent anti-phytopathogenic fungicides. FEMS Microbiol Lett 339:130–136
Xiao J, Zhang Q, Gao YQ, Tang JJ, Zhang AL, Gao JM (2014a) Secondary metabolites from the endophytic Botryosphaeria dothidea of Melia azedarach and their antifungal, antibacterial, antioxidant, and cytotoxic activities. J Agric Food Chem 62(16):3584–3590
Xiao J, Zhang Q, Gao YQ, Shi XW, Gao JM (2014b) Antifungal and antibacterial metabolites from an endophytic Aspergillus sp. associated with Melia azedarach. Nat Prod Res 28:1388–1392
Xu H, Lv M, Tian X (2009) A review on hemisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: 2003-2007. Curr Med Chem 16(3):327–349
Xu D, Zhang BY, Yang XL (2016) Antifungal monoterpene derivatives from the plant endophytic fungus Pestalotiopsis foedan. Chem Biodivers 13(10):1422–1425
Yadav M, Yadav A, Yadav JP (2014) In vitro antioxidant activity and total phenolic content of endophytic fungi isolated from Eugenia jambolana Lam. Asian Pac J Trop Med 7:S256–S261
Yadav AN, Kumar R, Kumar S, Kumar V, Sugitha T, Singh B, Chauhan VS, Dhaliwal HS, Saxena AK (2017) Beneficial microbiomes: biodiversity and potential biotechnological applications for sustainable agriculture and human health. J Appl Biol Biotechnol 5:1–13
Yang CPH, Horwitz SB (2017) Taxol®: the first microtubule stabilizing agent. Int J Mol Sci 17(8):18
Yedukondalu N, Arora P, Wadhwa B, Malik FA, Vishwakarma RA, Gupta VK, Ali A (2017) Diapolic acid A–B from an endophytic fungus, Diaporthe terebinthifolii depicting antimicrobial and cytotoxic activity. J Antibiot 70(2):212–215
Yehye WA, Rahman NA, Ariffin A, Hamid SBA, Alhadi AA, Kadir FA, Yaeghoobi M (2015) Understanding the chemistry behind the antioxidant activities of butylated hydroxytoluene (BHT): a review. Eur J Med Chem 101:295–312
You Y (2005) Podophyllotoxin derivatives: current synthetic approaches for new anticancer agents. Curr Pharm Des 11(13):1695–1717
Yu H, Zhang L, Li L, Zheng C, Guo L, Li W, Sun P, Qin L (2010) Recent developments and future prospects of antimicrobial metabolites produced by endophytes. Microbiol Res 165:437–449
Yu FX, Li Z, Chen Y, Yang YH, Li GH, Zhao PJ (2016) Four new steroids from the endophytic fungus Chaetomium sp. M453 derived of Chinese Herbal Medicine Huperzia serrata. Fitoterapia 117:41–46
Zhang J, Ge HM, Jiao RH, Li J, Peng H, Wang YR, WU JH, Song YC, Tan RX (2010) Cytotoxic chaetoglobosins from the endophyte Chaetomium globosum. Planta Med 76(16):1910–1914
Zhang G, Sun S, Zhu T, Lin Z, Gu J, Li D, Gu Q (2011a) Antiviral isoindolone derivatives from an endophytic fungus Emericella sp. associated with Aegiceras corniculatum. Phytochemistry 72(11–12):1436–1442
Zhang ZB, Zheng QG, Yan RM, Wang Y, Zou ZR, Zhu D (2011b) Endophytic fungus Cladosporium cladosporoides LF70 from Huperzia serrata produces Huperzine A. World J Microbiol Biotechnol 27:479–486
Zhang G, Zhang Y, Qin J, Qu X, Liu J, Li X, Pan H (2013) Antifungal metabolites produced by Chaetomium globosum no.04, an endophytic fungus isolated from Ginkgo biloba. Indian J Microbiol 53(2):175–180
Zhang H, Liu R, Zhou F, Wang R, Liu X, Zhang H (2014a) Antimicrobial metabolites from the endophytic fungus Aspergillus sp. of Eucommia ulmoides. Chem Nat Compd 50(3):526–528
Zhang Q, Xiao J, Sun QQ, Qin JC, Pescitelli G, Gao JM (2014b) Characterization of cytochalasins from the endophytic Xylaria sp. and their biological functions. J Agric Food Chem 62(45):10962–10969
Zhao Q, Tang XC (2002) Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparision with tacrine, donepezil, rivastigmine and physostigmine. Eur J Pharmacol 455:101–107
Zhao J, Mou Y, Shan T, Li Y, Zhou L, Wang M, Wang J (2010a) Antimicrobial metabolites from the endophytic fungus Pichia guilliermondii isolated from Paris Polyphylla var. yunnanensis. Molecules 15(11):7961–7970
Zhao J, Zhou L, Wang J, Shan T, lingyun Z, Liu X, Goa L (2010b) Endophytic fungi for producing bioactive compounds originally from their host plants. Appl Microbiol Microb Biotechnol 1:567–576
Zhao J, Sun W, Shan T, Mou Y, Lou J, Li Y, Wang M, Zhou L (2012a) Antimicrobial metabolites from the endophytic fungus Gliomastix murorum Ppf8 associated with the medicinal plant Paris Polyphylla var. yunnanensis. J Med Plant Res 6(11):2100–2104
Zhao JT, Fu Y, Luo M, Zu YG, Wang W, Zhao C, Gu C (2012b) Endophytic fungi from pigeon pea [Cajanus cajan (L.) Millsp.] produce antioxidant Cajaninstilbene acid. J Agric Food Chem 60(17):4314–4319
Zhao SS, Zhang YY, Yan W, Cao LL, Xiao Y, Ye YH, Zhao SS, Zhang YY, Yan W, Cao LL, Xiao Y, Ye Y (2017) Chaetomium globosum CDW7, a potential biological control strain and its antifungal metabolites. FEMS Microbiol Lett 364:1–6
Zheng C-J, Xu L-L, Li Y-Y, Han T, Zhang Q-Y, Ming Q-L, Rahman K, Qin LP (2013) Cytotoxic metabolites from the cultures of endophytic fungi from Panax ginseng. Appl Microbiol Biotechnol 97(17):7617–7625
Zhu D, Wang J, Zeng Q, Zhang Z, Yan R (2010) A novel endophytic Huperzine A-producing fungus, Shiraia sp. Slf14, isolated from Huperzia serrata. J Appl Microbiol 109:1469–1478
Zilla MK, Qadri M, Pathania AS, Strobel GA, Nalli Y, Kumar S, Guru SK, Bhushan S, Singh SK, Vishwakarma RA, Riyaz-Ul-Hassan S, Ali A (2013) Bioactive metabolites from an endophytic Cryptosporiopsis sp. inhabiting Clidemia hirta. Phytochemistry 95:291–297
Acknowledgments
The authors are grateful to the CNPq, CAPES, and FAPEMIG.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
de Carvalho, C.R. et al. (2019). Bioactive Compounds of Endophytic Fungi Associated with Medicinal Plants. In: Yadav, A., Singh, S., Mishra, S., Gupta, A. (eds) Recent Advancement in White Biotechnology Through Fungi. Fungal Biology. Springer, Cham. https://doi.org/10.1007/978-3-030-14846-1_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-14846-1_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-14845-4
Online ISBN: 978-3-030-14846-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)